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Metabolic systems are important to a wide variety of applications, including 
therapeutic development, agricultural crop production, and manufacturing of industrial 
chemicals. Developing metabolic models is one of the best approaches to study 
metabolism, as computational experiments are generally cheaper and faster to perform 
than experiments in a laboratory. While there are computational frameworks that can 
model large metabolic systems at steady state or the metabolite dynamics of a small 
number of key metabolic pathways, it is substantially more difficult to model the 
dynamics of metabolism at the genome scale. In this thesis dissertation, I present three 
computational platforms that address several of the challenges in developing dynamic 
genome-scale metabolic models. First, I devised a stepwise machine learning strategy for 
identifying the regulatory topology within metabolic systems, which can be used to 
construct more accurate metabolic models. I then developed a framework for inferring 
absolute concentrations from relative abundances in metabolomics data, which will allow 
metabolomics (the systems-scale study of metabolites) to be more easily used with 
metabolic modeling tools. Finally, I implemented new constraints within a linear 
programming dynamic modeling framework that increase its ability to model a wider 
variety of metabolic systems. Together, these three platforms create a cohesive workflow 








1.1 Metabolic Systems 
 As the set of chemical reactions that are necessary to sustain life, metabolism is 
one of the most critical processes in all organisms, from the smallest bacterium to the 
largest mammals. Metabolism generates energy for our bodies after we eat, directs 
chemical resources to our muscles after a workout, and even breaks down unnecessary 
chemicals into waste products as we sleep. Whether we are aware of it or not, metabolic 
processes are constantly working behind the scenes to ensure our bodies are functioning 
properly. When speaking of metabolism, one may initially think of its importance in 
humans and how it pertains to topics such as weight-loss and aging. What some people 
may not realize is that metabolism also plays a key role in various diseases1, drug 
discovery2, and developing personalized medical treatment for patients3. 
Though understanding human metabolism clearly has biomedical relevance, there 
is also great interest in studying the metabolism of other species, including the model 
organisms Escherichia coli and Saccharomyces cerevisiae. Metabolism in these two 
unicellular organisms, and others like them, is less complex than the organism-scale 
metabolism found in humans, but it is still incredibly valuable to science. While the most 
important pathways, such as those in central carbon metabolism, are topologically well-
conserved across different species4, many organisms have unique metabolic reactions or 
are able to produce certain chemicals in much higher quantities than other species due to 
corresponding fitness advantages that have been selected for over the course of evolution. 




cerevisiae, a popular yeast species in the culinary arts, brewing, and bioresearch because 
of its innate ability to produce ethanol and CO2 during fermentation
5. Studying the 
differences in metabolism across various organisms can provide meaningful insight about 
the importance of certain metabolic pathways. 
 Besides just studying the metabolism of microorganisms, scientists also engineer 
metabolism, using genetic modifications to reroute metabolic resources and produce high 
quantities of molecules of interest. Heterologous pathways can even be introduced into 
the system to allow the cell to synthesize products it otherwise could not6. This practice 
of designing and engineering pathways is known as metabolic engineering7. The field of 
metabolic engineering has rapidly expanded over the last few decades8 as researchers 
have harnessed its potential to engineer organisms to produce valuable chemicals that 
would otherwise be too expensive or too difficult to manufacture via chemical synthesis. 
Metabolic engineering has proven useful in a wide variety of applications including 
therapeutic development9, agricultural crop production10, and renewable energies11. In the 
next sections, I discuss the data used to understand metabolic systems. 
 
1.2 Metabolomics 
 To study metabolism in a range of organisms, metabolomics has emerged as a 
valuable -omics field, following in the footsteps of transcriptomics, proteomics, and 
genomics. Metabolomics is defined as the systems-scale study of metabolites, the 
chemical intermediates used to sustain life12. Whereas transcriptomics, proteomics, and 
genomics provide more upstream views of cellular functions, metabolomics is a direct 




metabolomics has been used in a wide variety of applications. 
 
1.2.1 Applications of metabolomics 
 Perhaps the most immediate and widely-known uses of metabolomics relate to 
human metabolism. One of the most important applications of metabolomics is its use in 
medicine as a tool to identify disease biomarkers1. By comparing the metabolite profiles 
of cancer patients to those of healthy individuals, metabolomics has elucidated key 
metabolite biomarkers that have been helpful in disease prognosis or monitoring disease 
progression13. Metabolomics has also provided insight for better understanding and 
preventing diseases in the first place14. Many common diseases15, such as heart disease, 
diabetes, Parkinson’s, and various cancers, are known to have clear connections with 
metabolism, which has led to great interest in using metabolomics to develop and screen 
new drugs. When testing different drug candidates, metabolomics can help determine 
which candidates affect specific metabolic pathways based on the metabolic changes they 
induce16, 17. This is especially important in determining if a drug candidate could lead to 
toxic levels of certain metabolites within the body. Recently, the idea of using 
metabolomics in personalized medicine3, where medical treatment is tailored specifically 
to a patient’s metabolome, has also gained popularity. 
 Metabolomics has not only been used to study metabolism in people, but it has 
also had a significant impact on plant and microbial research. In plant sciences, 
metabolomics has generated insight about plant response to changing environments18, 
antimicrobial resistance in agricultural crops19, differences in metabolic profiles between 




incredibly beneficial for disease research. In particular, yeast metabolomics has been 
used to study cancer22 and bacterial metabolomics has the potential to reveal quorum 
sensing metabolites that could mitigate the effects of bacterial infections23. Additionally, 
the link between metabolomics and the gut microbiota has helped researchers understand 
how our bodies breakdown food or foreign substances, such as pharmaceutical drugs24.  
Metabolomics has also garnered interest as a tool for building metabolic models25, 
as it can contribute a large amount of metabolic information. Despite providing direct 
insight on how metabolic resources are being consumed or produced, one area in which 
metabolomics has been used surprisingly little is metabolic engineering26. One of the 
most challenging obstacles to using metabolomics in metabolic engineering and other 
analytical tools is how limited raw metabolomics data can be without using standards for 
each metabolite. Because the properties of different chemicals cause metabolites to be 
measured relatively instead of absolutely, it is not possible to compare the quantities of 
different metabolites to each other. Below, I discuss the different analytical instruments 
used to measure metabolomics and further expand on the current limitations of using 
metabolomics data with metabolic tools. 
 
1.2.2 Methods for measuring metabolomics data 
 There are three common analytical techniques used to measure metabolomics 
data. Nuclear magnetic resonance (NMR) spectroscopy uses strong magnetic fields to 
measure chemicals that behave differently based on the nuclei in their atoms. One key 
advantage of using NMR is that it is a nondestructive method, meaning samples can be 




hundreds or thousands of metabolites at low concentrations, researchers typically turn to 
gas chromatography or liquid chromatography coupled to mass spectrometry (GC-MS 
and LC-MS, respectively). GC-MS primarily separates chemicals in the gas column 
based on their boiling points and their affinity for the chromatography column, and then 
the molecules in the sample are ionized and further separated via a mass spectrometer. 
Prior to injection into a GC-MS instrument, samples must be derivatized because many 
chemicals are not volatile enough to be vaporized effectively in their native states28. The 
advantage of LC-MS is that no derivatization is necessary because chemicals are 
separated in a liquid phase based on their interactions with a stationary phase in the 
column instead of in the gas phase.  
Both GC-MS and LC-MS have become increasingly popular29 and arguably the 
preferred analytical tools to measure metabolites, but it is difficult to quantify absolute 
concentrations of metabolites using either method. The data that these two mass 
spectrometry approaches yield are relative, rather than absolute, abundances. While the 
relative abundances of a single metabolite can be compared across different timepoints or 
different samples in an experiment, comparing the relative abundances of different 
metabolites has little quantifiable meaning (Figure 1), making it difficult to integrate 
metabolomics data into many analytical tools, including computational modeling 
frameworks. When quantification of only a few metabolites is required, researchers can 
use chemical standards to measure absolute concentrations. Unfortunately, chemical 
standards can be expensive, time-consuming to run, and unavailable for many 
metabolites30-32. Developing a platform for inferring absolute concentrations without the 




both present and future metabolic tools. 
 
 
Figure 1: Example of a chromatogram. 
Peaks in a chromatogram ideally represent different metabolites. Because metabolites are 
often measured in terms of relative abundances, the quantities of different metabolites 
cannot be directly compared. 
 
1.3 Metabolic Modeling Approaches 
 There are two fundamental class of approaches researchers use to model 
metabolism33. Constraint-based models use linear programs to efficiently model 
metabolic systems, while ordinary differential equation-based models use detailed kinetic 
equations to accurately model reactions. The advantages and disadvantages of these 
approaches are discussed in detail in this section. 
 
1.3.1 Constraint-based modeling 
Constraint-based models (CBMs) are arguably the most popular metabolic 
modeling approach because they can be easily developed for any system in which the 
stoichiometry of reactions is known. The quintessential CBM method in metabolic 




steady-state and therefore the metabolite concentrations do not change over time. This 
assumption forces the influxes and effluxes of each metabolite to cancel out, which leads 
to a system of linear mass balance equations based on the stoichiometry of the system. 
The fluxes within this system of equations can be easily calculated using linear algebra 
tools without needing to estimate any kinetic parameters, one of the most appealing 
aspects of FBA. In biological systems, these systems of stoichiometric equations are 
generally underdetermined (i.e. there are more unknown fluxes than metabolites), leading 
to an infinite number of possible flux solutions. To overcome this obstacle, FBA 
implements constraints on the fluxes and most importantly, an objective function. The 
objective function is typically some hypothesized biological goal of the organism (i.e. 
maximizing biomass or ATP production), reflecting some evolutionary pressure for cell 
survival35. Together, the system of mass balance equations, flux constraints, and 
objective function create a linear program (LP), a mathematical optimization problem 
that can be solved efficiently even for large-scale problems, which is a key reason why 




                                    𝑠. 𝑡.    𝑆 ∙ 𝑣 = 0  (Equation 1) 
𝑣𝐿𝐵 < 𝑣 < 𝑣𝑈𝐵 
 
where c is a vector of weights that determine the objective function, v is the flux vector, S 




metabolite, and vLB and vUB are vectors of the lower and upper bounds for each flux, 
respectively. 
While FBA models are easy to develop for many biological systems due to their 
LP structure, their assumption of steady state precludes capturing any metabolite 
dynamics. The steady-state assumption is useful for understanding the metabolism of an 
organism under static conditions, but cells are generally not at steady-state due to 
constant changes in the extracellular environment. Nevertheless, FBA is one of the best 
modeling tools to efficiently study metabolism at any scale and predict how metabolic 
resources are generally being produced and used. 
 
1.3.2 Examples of constraint-based models 
As the most common CBM approach in metabolic modeling, FBA has led to the 
development of numerous frameworks that are heavily influenced by or are direct 
extensions of the original FBA. Each of these new modeling approaches aim to 
supplement the relatively simple structure and assumptions of FBA, often integrating new 
biological information that improves modeling accuracy. Energy balance analysis 
(EBA)36, thermodynamic metabolic flux  analysis (TMFA)37, and network-embedded 
thermodynamic analysis (NET analysis)38 have incorporated thermodynamic constraints 
into their frameworks to eliminate flux distributions that are not energetically feasible39. 
Other methods, such as Minimization of Metabolic Adjustment (MoMA)40 and 
parsimonious flux balance analysis (pFBA)41 find flux distributions that are least taxing 
to the cell. MoMA predicts flux distributions in the feasible search space that are closest 




objective function while concurrently minimizing the total flux. 
There have also been several extensions of FBA that attempt to track dynamic 
changes in metabolic systems. Recently, unsteady-state flux balance analysis (uFBA)42 
demonstrated it could predict dynamic metabolic flux states in several systems by using a 
novel piecewise simulation method that determines if a system is at steady-state based on 
the rates of change of its metabolites. Dynamic Flux Balance Analysis (DFBA)43 in 
particular has garnered a substantial amount of attention as one of the first FBA-based 
methods to attempt to capture metabolite dynamics. DFBA uses two formulations to track 
dynamics: the Dynamic Optimization Approach (DOA) and the Static Optimization 
Approach (SOA). Although the DOA method is more accurate, it contains many non-
linear constraints that make it more computationally taxing to use. The SOA formulation 
is much simpler and can still model metabolite dynamics, but it is unable to incorporate 
regulatory information like DOA. DFBA was a significant step in bridging the gap 
between CBM and ODE-based models, but most researchers still prefer kinetic models 
when accurate representations of metabolic systems are required. Overcoming the 
limitations of DFBA will be critical toward efficiently developing dynamic metabolic 
models at the genome scale. 
 
1.3.3 Ordinary differential equation-based modeling 
While CBMs excel at developing relatively simple models for systems of all 
sizes, ODE-based models use detailed kinetic equations to accurately model biological 
reactions. These kinetic equations allow for ODE-based models to track changes in 




equations typically include several kinetic parameters that need to be estimated if they are 
not known a priori, which is often the case. While parameter estimation is achievable 
when there are only tens of reactions, it quickly becomes infeasible as the size of the 
modeled system increases due to the ample amount of data necessary to identify 
parameters accurately. This scaling problem makes it difficult to create kinetic models at 
the genome scale and is why most large models consisting of hundreds or thousands of 
metabolites and fluxes are developed using CBMs. 
 
1.3.4 Examples of ODE-based models 
 As one of the most studied organisms, there are several kinetic models that have 
been developed for E. coli44-46. These ODE-based models have been used to predict 
different growth rates due to genetic perturbations and the increased biosynthesis of 
various target molecules, which make these models attractive for metabolic engineering 
applications. There have also been numerous ODE-based models developed for S. 
cerevisiae47, 48, as it is one of the most important eukaryotic species in metabolism 
research. Like E. coli, kinetic models of S. cerevisiae have been vital to metabolic 
engineering, especially in the study of ethanol production49. While E. coli and S. 
cerevisiae are certainly two of the most widely-studied and kinetically modeled 
microorganisms, other scientifically relevant systems, such as Lactococcus lactis50 and 
Pseudomonas putida51, have also been modeled using ODEs. 
Many of these kinetic models focus on central carbon metabolism, as it arguably 
contains the most important pathways in metabolism and is small enough that parameter 




sections of metabolism, there have been a few attempts at constructing genome-scale 
kinetic models. An ODE-based model of E. coli metabolism was recently developed 
using Michaelis-Menten based kinetics with ensemble modeling and genetic algorithms 
for parameter estimation and was shown to predict several hundred engineered strains 
more accurately than other modeling approaches52. There have also been efforts to create 
more generalized approaches for developing genome-scale kinetic models53-55, but most 
still require lengthy parameter estimation steps, known kinetic constants, or are only 
useful near the reference state of the modeled system. Despite these attempts, there 
remains a divide between efficient modeling frameworks that are scalable and modeling 
approaches that capture metabolite dynamics. 
 
1.3.5 Linear Kinetics-Dynamic Flux Balance Analysis 
To bridge the gap between CBMs and ODE-based models, our group developed 
Linear Kinetics-Dynamic Flux Balance Analysis (LK-DFBA)56. LK-DFBA is a novel 
modeling framework that can track metabolite dynamics while maintaining an LP 
structure, which is a significant step toward efficiently modeling biological systems at the 
genome scale. LK-DFBA is inspired by the work presented in DFBA and attempts to 
combine the strengths of the DOA and SOA formulations. LK-DFBA introduces novel 
linear kinetics constraints that model the interaction between a controller metabolite and 
the target flux that it regulates. These constraints are the driving force behind metabolite 
accumulation and depletion by constraining the maximum reaction rates of fluxes based 
on the metabolite concentration at a given time. Both mass action and allosteric 




We have previously demonstrated that LK-DFBA can recapitulate the training 
data of a synthetic system and a kinetic model of E. coli44. However, LK-DFBA has not 
been used to predict phenotypes when using different initial metabolite concentrations or 
introducing perturbations to pathways in the system. Before LK-DFBA can become a 
prominent metabolic modeling framework, it needs to at least be validated on data that is 
not used to train the actual model. Furthermore, one key area that could be improved in 
LK-DFBA is the construction of the kinetics constraints. In the original framework, the 
kinetics constraints are crude linear approximations of interactions between metabolites 
and fluxes. New kinetics constraints that better capture biological phenomena could lead 
to an increase in modeling accuracy. 
 
1.4 Regulation in Metabolic Systems 
The only information classical FBA requires is the stoichiometric topology of the 
system, an objective function, and flux constraints to build a metabolic model. However, 
in many cases this is not enough to construct an accurate representation of the system. 
One important feature of metabolism that FBA does not account for is regulation within 
an organism. Regulation can significantly impact the rate of reactions and must be 
incorporated when developing accurate metabolic models. 
 
1.4.1 Transcriptional regulation 
Transcriptional regulation is one of the most well-known and widely-studied 
forms of regulation in biological systems. In transcriptional regulation, transcription of 




or decrease the amount of gene expression. Because gene expression ultimately leads to 
enzyme production (or lack thereof), transcriptional regulation can be an important factor 
in determining the rate of some metabolic reactions. However, because these 
transcription factors or other transcriptional regulatory proteins do not directly modulate 
enzyme activity, the timescale of these regulatory effects may not be immediately 
obvious57, 58. 
 
1.4.2 Allosteric regulation 
While transcriptional regulation occurs at the DNA level, allosteric regulation 
takes place at the metabolite level. Allosteric regulation results from a regulator, often a 
small molecule, interacting with a protein, such as an enzyme, at a location other than its 
active site59. Like transcription factors in transcriptional regulation, allosteric regulators 
can inhibit or induce their target. Besides acting as the primary substrate in many 
different metabolic reactions, metabolites are also often allosteric regulators in other 
reactions (Figure 2). Because allosteric regulation occurs at the metabolite level, it 
directly impacts the metabolic state of the system and occurs on timescales much faster 
than transcriptional regulation58, which makes it especially critical in understanding the 







Figure 2: Example of metabolite-dependent allosteric regulation. 
Metabolite x1 is the substrate of the reaction flux v1 and metabolite x2 is the product. 
Unlike x1, metabolite x3 is not consumed by the reaction but instead acts as a regulator 
that inhibits the reaction rate. 
 
 
1.4.3 Constraint-based modeling frameworks that integrate regulation 
There have been a few iterations of FBA that try to account for regulation in their 
frameworks. Regulatory flux balance analysis (rFBA)60, integrated flux balance analysis 
(iFBA)61, and  steady-state regulatory flux balance analysis (SR-FBA)62 are three 
methods created to incorporate transcriptional regulation into the original FBA 
formulation. Each uses Boolean notation to designate whether a gene is active or not. 
These frameworks were found to more accurately predict different phenotypes and better 
understand how transcriptional regulation affects metabolism. When implementing 
transcriptional regulation into such frameworks, pseudo “time delays” are often used to 
demonstrate the indirect impact of transcriptional regulation on metabolic activity. 
Despite its importance, allosteric regulation has not been integrated into CBMs as 
often. In ODE-based models, allosteric regulation can be readily implemented in a 
reaction by adding extra parameters and variables to its kinetic equation. There have only 
been a few attempts in the literature to integrate allosteric regulation with FBA. Allosteric 
Regulation FBA (arFBA)63 is an extension of pFBA that modifies the objective function 




flux ratio equal to the turnover rate (of metabolites that regulate the flux) ratio. One 
downside of using this method is that it assumes that the ratios of the flux and turnover 
rate are exactly equal to each other, providing no flexibility. In LK-DFBA we have 
implemented allosteric regulation within the linear kinetics constraints.  
 
1.4.4 Determining the topology of allosteric regulation 
Although allosteric regulation is prevalent in most biological systems, the 
regulatory topology of different metabolic systems is often unknown. In contrast to the 
stoichiometry of metabolic reactions, which is relatively well-conserved across species64, 
regulation can vary greatly. It can be difficult to experimentally identify the regulatory 
structure of a system because of the vast number of metabolites that could act as 
regulators for each reaction in metabolism. Without knowing how metabolic reactions are 
regulated, it is challenging to accurately model metabolism. As transcriptomics and 
genomics are currently much more mature fields than metabolomics and fluxomics, there 
have been many computational frameworks developed to map out transcriptional 
regulation in cells65-72.  
Computational methods for identifying allosteric regulation have been less 
common, though there are a few approaches that have been developed. Link et al. used 
ensemble modeling to establish the most likely regulatory structures of reactions58. In 
another approach, systematic identification of meaningful metabolic enzyme regulation 
(SIMMER)73 uses non-linear optimization to fit data to simple Michaelis-Menten kinetic 
equations and determine if additional regulatory elements are required to sufficiently 




difficult to obtain for lesser-studied organisms. New methods for determining the 
topology of allosteric regulation are highly desirable. 
Machine learning has become a popular approach for finding patterns within large 
datasets and creating predictive models using artificial intelligence. By training machine 
learning algorithms on “training data,” models have been developed to predict protein 
structures, gene function, and gene regulation74. In the context of metabolomics, machine 
learning has been previously used to impute missing values75 and discover new 
biomarkers76, but it has not been used to identify the regulatory topology of metabolic 
systems. Applying machine learning to discover new regulatory interactions could enable 
development of accurate metabolic representations of systems where regulation has been 
poorly characterized. 
 
1.5 Thesis overview 
With applications in medicine, agriculture, energy, and more, the importance of 
studying metabolic systems is evident. Researchers have demonstrated that combining 
metabolomics with computational modeling has led to new insight into metabolic 
systems and it will continue to be a critical step toward understanding metabolism at the 
genome scale. Here, I have discussed several key areas in metabolic modeling that need 
to improve to create a streamlined process for modeling metabolic systems given only 
raw metabolomics data and the stoichiometry of the system. First, allosteric regulation in 
organisms that are not well-studied is often unknown, which can make it difficult to 
model metabolite dynamics. Second, while metabolomics is a direct readout of a system’s 




computational tools, any quantification of metabolites is often in terms of relative 
abundances, which makes it difficult to compare different metabolites to each other. 
Finally, although CBMs are more efficient and scalable in modeling different biological 
systems compared to ODE-based frameworks, they lack the ability to capture metabolite 
dynamics. LK-DFBA is a new framework that combines the advantages of both CBMs 
and ODE-based models, but there are still several areas that must be improved before it 
can become an invaluable tool in the metabolic modeling community. In this thesis, I aim 
to address each of these concerns and create a cohesive workflow for developing 




CHAPTER 2: A Stepwise Machine Learning Framework for Predicting 





Biochemists have amassed a large amount of knowledge about the topology of the 
chemical reaction network that cells use to transform nutrients into energy and the 
building blocks for more cells, collectively known as “metabolism”. The substrates, 
products, and cofactors for hundreds of reactions have been elucidated, from the most 
central pathways like glycolysis to more distant pathways for the biosynthesis of 
uncommon metabolites. Many of these pathways are extremely well-conserved across the 
tree of life64, with the basics of central carbon metabolism being quite similar from 
bacteria to humans. What varies much more greatly across species, and what allows such 
diverse metabolic phenotypes to arise from such otherwise similar reaction networks, is 
the regulation and utilization of the reactions in those networks. However, this regulation, 
despite its major importance in the function and diversity of life, is nowhere near as well 
understood as the topology of the metabolic network46. This is especially true for the 
direct regulation of reactions by metabolites, which is particularly poorly characterized 
compared to some other levels of regulation like transcriptional regulation. This is in 
large part due to the difficulty in experimental characterization of direct regulation by 
metabolites. 
 One critical form of direct regulation of metabolic reactions (and arguably the 
most common) is allosteric regulation, where a regulator and a protein (in this case an 




that is not the primary substrate of an enzyme binds to that enzyme and inhibits or 
promotes the reaction rate, most typically via an induced change in protein conformation. 
While metabolite levels can affect processes on the genome, transcriptome, and proteome 
levels78, metabolite-dependent regulation of enzyme reaction rates is extremely important 
because it results in the control of reactions on a short timescale (less than 30 seconds) 
due to the direct interaction between metabolite and enzyme rather than requiring 
intermediate steps like transcription to effect changes58, 63. Their prevalence in metabolic 
systems makes it vital to account for these regulatory interactions to create accurate 
metabolic models.  
Metabolic models that use only the known stoichiometry of the system and 
exclude metabolite-dependent regulation often have extremely limited accuracy. 
Machado et al. showed that including allosteric regulation in a model of E. coli is vital for 
predicting flux dynamics and can reveal “metabolic hubs,” where a metabolite is 
connected to many reactions instead of only the few found in the stoichiometric 
topology63. Despite its prevalence and importance, the exact structure of this regulatory 
network (which metabolites regulate which fluxes) is typically unknown in all but the 
best-studied metabolic pathways in the best-studied organisms. With hundreds of 
metabolites and hundreds of fluxes in any given metabolic network and no effective high-
throughput methods for finding metabolite-protein interactions (compared to, for 
example, protein-protein interactions79, 80), the space of possible regulatory interactions is 
too vast to experimentally explore81. 
As discussed at the beginning of this thesis, there have only been a few 




enzymes in metabolic systems. Link et al.58 used dynamic metabolite data to fit an 
ensemble of kinetic models with different putative regulatory interactions to rank which 
interactions contributed the most to fitting accuracy. Another approach by Hackett et al., 
named SIMMER73, estimated kinetic parameters using non-linear optimization to 
establish if all reactions in a system could be sufficiently explained by Michaelis-Menten 
kinetics or if additional allosteric parameters were required. While these computational 
approaches are invaluable in saving time and costs for laboratory experiments, both 
methods rely on sampling58 or estimating73 kinetic parameters, which can be 
computationally taxing. An approach for identifying metabolite-dependent regulatory 
interactions without requiring kinetic parameters would be extremely useful for systems 
biology modeling. Although approaches using protein docking, such as AlloFinder82, are 
promising for future ab initio prediction of regulatory interactions, current limitations in 
the accuracy of molecular simulations make systems-scale exploration of allosteric 
interaction space challenging and motivate a desire for approaches that can exploit 
increasingly widely available experimental datasets for these purposes. 
Here, we present a new machine learning approach for Stepwise Classification Of 
Unknown Regulation (SCOUR) that leverages metabolomics and fluxomics data to 
predict likely metabolite-dependent regulatory interactions. SCOUR uses a stepwise 
process that focuses on identifying reactions controlled by one, two, or three metabolites. 
While SCOUR benefits from stepwise, serial inference of these increasingly complex 
interactions, each step is independent, uses different classification features, and can be 
performed without the others. Importantly, the classification task that SCOUR looks to 




devise a strategy we refer to as “autogeneration” that we use to create sufficient data to 
train the models.  We test our framework on two synthetic model networks, as well as on 
models of S. cerevisiae and E. coli metabolism, to show that SCOUR can be used on a 
variety of systems. Applying SCOUR to poorly-studied organisms has the potential to 
enable discovery of previously unknown regulatory interactions that are key to 
developing accurate and predictive metabolic models. 
 
 
2.2 Methods for Predicting Regulatory Interactions 
In this work, we examined four metabolic networks of varying size and 
complexity: two synthetic model networks and two biological systems. We simulated 
each metabolic network with fifteen sets of randomly generated metabolite concentration 
initial conditions (except for the first set of initial conditions for the biological systems, 
which were kept at their original values) to produce fifteen sets of metabolite 
concentration and flux data used in the testing sets of SCOUR. Each metabolic network is 
described in detail below. 
 
2.2.1 Synthetic model networks 
 To initially test and evaluate SCOUR, we created two small synthetic model 
networks. The Smaller Synthetic Model (Figure 3A) contains six metabolites and six 
reactions, while the Bigger Synthetic Model (Figure 3B) contains ten metabolites and ten 
fluxes. Synthetic systems of these sizes are small and simple enough to easily assess the 
performance of SCOUR while developing the framework, but large enough to emulate 




(v1) is a constant flux that is not controlled by any metabolites and is not considered when 
using SCOUR. Both models contain reactions controlled by one, two, or three 
metabolites, including both positive and negative regulatory interactions. Table 3 
summarizes the number of each type of interaction in each model. The network dynamics 
were defined using Biochemical Systems Theory (BST) equations using power law 
kinetics for reaction rates83, with mass action parameters randomly assigned between 0.1 
and 1 and regulation parameters randomly assigned between 0.1 and 1 for positive 
regulatory interactions and between -1 and -0.1 for negative regulatory interactions. Each 
model was simulated for 10 seconds to generate synthetic data. 
 
 
Figure 3: Synthetic systems tested with SCOUR. 
Two synthetic model networks created using BST frameworks to generate in silico 
metabolomics and fluxomics data. xi represent metabolites, vi represent reaction fluxes 
(solid black lines), long-dashed red lines represent regulatory behavior that causes 
inhibition, and short-dashed green lines represent regulatory behavior that increases 
activity. 
 
2.2.2 Biological models 
 To test SCOUR on more biologically relevant systems, we examined a model of 




Escherichia coli44. The S. cerevisiae model contains 22 metabolites and 24 reactions, 
while the E. coli model contains 18 metabolites and 48 reactions. We used the previously 
published kinetic equations and parameters for these systems; in both cases, the 
mathematical forms of the rate expressions include Michaelis-Menten, Hill, and mass 
action kinetics. Data for both biological systems were produced by reconstructing the 
ODE models in MATLAB and simulating the S. cerevisiae and E. coli models over 60 
seconds and 10 seconds, respectively.  
In the S. cerevisiae model, the fluxes for glucose mixed flow to extracellular 
medium and cyanide flow are constant and not controlled by any metabolites (Table 1). 
Likewise, in the E. coli model, the fluxes for glucose kinetics, murein synthesis, 
tryptophan synthesis, and methionine synthesis are constant and not controlled by any 
metabolites (Table 2). As in the synthetic models, both the S. cerevisiae and E. coli 
models include reactions controlled by one, two, or three metabolites, although they also 
have reactions controlled by four metabolites. Table 3 summarizes the number of each 
type of interaction in each of the four systems. Because both biological models have 
significantly more metabolites and reactions than the synthetic models, the number of 
possible interactions that need to be considered is substantially greater. 
 
Table 1: List of controller metabolites and target fluxes in S. cerevisiae model. 
Controller metabolite(s) Target flux 
N/A Glucose mixed flow to extracellular 
medium 
Extracellular glucose Glucose uptake 
























ADP, phosphoenolpyruvate Pyruvate kinase 
Pyruvate Pyruvate decarboxylase 
NADH, acetaldehyde Alcohol dehydrogenase 
Ethanol, extracellular ethanol Ethanol out 
Extracellular ethanol Ethanol flow 
Dihydroxyacetone phosphate, NADH, 
NAD 
Glycerol synthesis 
Glycerol Glycerol out 
Glycerol, extracellular glycerol Glycerol flow 
Acetaldehyde, extracellular acetaldehyde Acetaldehyde out 
Extracellular acetaldehyde Acetaldehyde flow 
Extracellular acetaldehyde, extracellular 
cyanide 
Cyanide-acetaldehyde flow 
N/A Cyanide flow 
ATP, glucose-6-phosphate Storage 
ATP ATP consumption 
AMP, ADP, ATP Adenylate kinase 
 
Table 2: List of controller metabolites and target fluxes in E. coli model. 
Controller metabolite(s) Target flux 











































N/A Tryptophan synthesis 




3-Phosphoglycerate Serine synthesis 










Phosphoenolpyruvate Synthesis 1 




Pyruvate Pyruvate dehydrogenase 
N/A Methionine synthesis 
6-Phosphogluconate 6-Phosphogluconate dehydrogenase 








Glucose-6-phosphate G6P degradation 
Fructose-6-phosphate F6P degradation 
Fructose-1,6-bisphosphate FDP degradation 
Glyceraldehyde-3-phosphate GAP degradation 




Table 2 (continued) 
1,3-diphosphosphoglycerate PGP degradation 
3-phosphoglycerate PG3 degradation 
2-phosphoglycerate PG2 degradation 
Phosphoenolpyruvate PEP degradation 
Pyruvate Pyruvate dilution 
6-phosphogluconate PG dilution 
Ribulose-5-phosphate Ribu5P dilution 
Xylulose-5-phosphate XYL5P dilution 
Sedoheptulose-7-phosphate SED7P dilution 
Ribose-5-phosphate Rib5P dilution 
Erythrose-4-phosphate E4P dilution 
Glucose-1-phosphate G1P dilution 
 
Table 3: The number of n-controller metabolite interactions that exist in or are 
possible for each model. 
For possible interactions, the first number assumes that regulatory interactions are 
correctly identified at each step of the framework and are removed from consideration for 
higher-order interactions. The number in parentheses is the total number of possible 
interactions if a stepwise framework were not used, illustrating the significant decrease in 
the number of interactions to be assessed in a stepwise framework. 




S. cerevisiae E. coli 
# of 1-controller 
interactions 
1 3 5 25 
# of possible 1-
controller 
interactions 
5 9 12 39 
# of 2-controller 
interactions 
2 3 10 13 
# of possible 2-
controller 
interactions 
20 (25) 54 (81) 157 (262) 243 (668) 
# of 3-controller 
interactions 
2 3 5 2 
# of possible 3-
controller 
interactions 
20 (50) 108 (324) 520 (2720) 336 (5384) 
# of 4-controller 
interactions 
N/A N/A 2 4 
# of possible 4-
controller 
interactions 







2.2.3 Autogenerated training data 
 Machine learning models must be trained using data that are broadly 
representative of the input data they are likely to encounter, which often entails using 
datasets that are as large as possible. In metabolism, there is a wide variety of metabolic 
reactions with disparate mechanisms and functional behaviors (e.g. bi-bi sequential 
reactions vs. ping-pong reactions)84 or that are controlled by a different number of 
metabolites. However, appropriate training data for many of these possible situations are 
sometimes not available at all, let alone in sufficient quantity to enable machine learning 
model training. Accordingly, we chose to generate hundreds of artificial interactions to 
use as training data in an approach we refer to as “autogeneration”. While the practice of 
creating artificial training data has been used in other machine learning contexts before85-
88, to the best of our knowledge it has not been used in producing metabolite-dependent 
regulatory interaction data.  
For the training datasets in each step (meaning for the 1-controller, 2-controller, 
and 3-controller metabolite interactions), we created 300 autogenerated interactions, each 
with 15 different initial conditions. The 300 interactions included a mixture of samples 
that resembled true positive and true negative interactions. To create the time course data 
for each controller metabolite, concentration profiles were created from damped sine 
wave functions with randomized parameters (Equation 2). xi is the concentration of 
controller metabolite i, t is the simulation time, and A, λ, ω, φ, are the amplitude, decay 
constant, angular frequency, and phase angle of a damped sine wave: 
 
𝑥𝑖 = 𝐴𝑖𝑒




 These concentration profiles were then used as input into BST equations to 
calculate dynamic flux profiles (Equation 3). BST is an ordinary differential equation-
based modeling framework for metabolic systems that uses power-law kinetics and is 
generalizable to many types of metabolic reactions83. Each BST equation also was 
assigned randomized parameters. v represents the target reaction flux (rate), xi is the 
concentration of controller metabolite i, n is the number of controller metabolites that 
regulate the target flux, and α and β are the randomly assigned BST parameters. 
 
𝑣 = 𝛼 ∏ 𝑥𝑖
𝛽𝑖𝑛
𝑖=1   (Equation 3) 
 
After generating both controller metabolite and target flux data, interactions were 
randomly assigned as either true positives or true negatives. If the interaction was labeled 
as a true positive, the correct sets of simulated controller metabolite profiles and 
corresponding calculated target flux profiles were used when calculating machine 
learning model features. However, if the interaction was labeled as a true negative, 
another set of metabolite concentration time course profiles would be generated from new 
damped sine wave functions and be used with the original target flux data to calculate 
features. Because these new pseudo-controller metabolites were not used in the 
calculation of the target flux data, there should be minimal relationship between the 
metabolites and the target flux, yielding a “true negative” data point. 
  To emulate the percentage of true positive interactions in the models tested in this 
work, of the 300 interactions in each step, 40%, 5%, and 5% were randomly assigned as 




respectively. Changes to these percentages are expected to shift the sensitivity and 
specificity of the framework, so it is important to base the training percentages on what is 
expected to be seen in the testing data based on existing biochemical knowledge. 
This approach for autogenerating training data aims to circumvent the 
requirement for large dynamic metabolomics and fluxomics datasets to train the machine 
learning framework, which are currently not widely available on the scale that would be 
required. Because this autogeneration approach is independent of SCOUR, it can possibly 
be used for other computational methods that require an abundance of metabolic data.  
 
2.2.4 Noise-added data 
To generate noisy data that are more representative of what is expected to be 
acquired experimentally, we used two different sampling frequencies and two 
coefficients of variation (CoV) for randomly-added noise, for a total of four conditions. 
Sampling frequencies of 50 and 15 timepoints (nT) and CoVs of 0.05 and 0.15 were used, 
where a higher CoV represents more noise (experimental error). The number of 
timepoints and amount of added noise are reasonable values for what one could possibly 
expect from mass spectrometry data for metabolomics or fluxomics. Starting with 
noiseless data, each metabolite and flux value in each time course was replaced with a 
random value drawn from 𝑁𝑖,𝑘 ~ (𝑦𝑖(𝑡𝑘),𝐶𝑜𝑉∙𝑦𝑖(𝑡𝑘)), where 𝑦𝑖(𝑡𝑘) is the value of species 
(metabolite or flux) 𝑖 at timepoint 𝑘. For each timepoint, three noisy data values were 
generated to resemble triplicate samples, which is a common practice in metabolomics 





2.2.5 Data pre-processing 
 For noisy data, we applied two different pre-processing steps to the data. For the 
one-controller metabolite interaction inference step of the framework, we used the 
median sample of the triplicate noisy data to calculate the features in the training and 
testing sets. For the two- and three-controller metabolite interaction inference steps, 
instead of using the medians, a moving Gaussian filter was applied to smooth the 
triplicate noisy data before calculating their features. The window size of the filter was 
chosen to be ¼ of the total simulation time, which was found to smooth the data without 
overfitting to the noise itself. While smoothing the noisy data for two- and three-
controller metabolite interactions led to an increase in SCOUR’s performance, it was 
detrimental for one-controller metabolite interactions. We found that a few of the one-
controller metabolite interaction features were more sensitive to the smoothed data than 
the noisy median data and would cause greater variability in SCOUR’s performance 
across repetitions.  
 
2.2.6 Features 
Each step of the framework contains different “features” (Table 4) used to predict 
whether a particular interaction is likely to be correct. These “features” are scalar-valued 
outputs of functions that quantify characteristics of concentration and flux profiles and 
the relationships between different profiles, which may thus indicate whether a given 
metabolite or set of metabolites regulates a given flux.  Different features were used for 
the prediction of interactions controlled by different numbers of metabolites (i.e., one-




features to be customized to specific interaction types (and avoids the requirement that 
they must be valid or useful for all interaction types), which is expected to increase 
SCOUR’s overall accuracy compared to using the same features for all steps. Features 
were designed using biochemical insight into how metabolites are known to interact with 
enzymes and how these interactions would manifest in concentration and flux profile 
data. For example, for the one-controller metabolite interaction step, the Spearman 
correlation between fluxes and metabolites was used as a feature, as reaction fluxes are 
expected to be highly (though not necessarily linearly) correlated with the metabolites 
that control them. Additionally, features were created based on the expectation that for 
every set of metabolites that completely defines an output flux, each possible set of 
metabolite input concentrations can only yield one single output of flux reaction rate. A 
list and description of all features used in SCOUR can be found in Table 4. 
 
Table 4: List of features for each step of the framework 
1-controller metabolite interaction features 
Feature name Description Reasoning for feature 
Correlation Spearman correlation between controller 
metabolite and target flux. 
If a reaction flux is controlled by a 
single metabolite (most likely a mass 
action interaction), the Spearman 
correlation should be close to +1. 
Curve fit A second-degree polynomial is fit to the 
controller metabolite vs. target flux data 
and the adjusted R2 value (adjusted for 
the number of coefficients in the 
polynomial model) is calculated. 
A simple polynomial curve should fit 
the data reasonably well if a reaction is 
controlled by a single metabolite (e.g. 
if the data exhibits a Michaelis-
Menten saturation curve). 
Flux prediction 2/3 of the available controller metabolite 
data and target flux data are randomly 
selected to train a kNN regression 
model, with the flux data acting as the 
dependent variable. The remaining 1/3 
of controller metabolite data is used 
with the kNN model to predict the 
remaining flux values and the prediction 
error is calculated. This process is 
repeated 3 times and the mean of the 
prediction errors is taken. 
It is likely easier to make predictions 
(i.e. lower prediction error) if the 
controller metabolite and target flux 
belong to an existing interaction in the 
system and no other metabolites truly 





Table 4 (continued) 
CoV of data The average CoV of the target flux is 
calculated at 10 evenly-spaced 
individual concentrations within the 
range of the controller metabolite. 
Because flux data may not be sampled 
at these evenly-spaced concentrations, 
flux data are linearly interpolated at 
these concentrations using the closest 
higher and lower concentrations with 
sampled flux data. 
The CoV of the target flux should be 
low at each metabolite concentration 
for a one-controller metabolite 
interaction because there should be a 
single flux value for every 
concentration value. 
2-controller metabolite interaction features 
Feature name Description Reasoning for feature 
Functionality Plot the two putative controller 
metabolites against each other for all 15 
datasets produced from different initial 
conditions. Identify where the two 
controller metabolite concentrations are 
approximately equal to each other in 
two of the datasets by finding where the 
two datasets intersect with each other on 
the plot. This is accomplished by using 
the InterX function in MATLAB89 that 
uses vectorization to determine 
intersection points between datasets. At 
these intersection points, linearly 
interpolate the flux data for each of the 
two datasets (using the 
scatteredInterpolant function in 
MATLAB for 3-D interpolation), 
calculate the difference of these two 
interpolated target flux values, and 
divide by the mean of the flux values to 
normalize. For all intersection points 
found, take the mean of all normalized 
differences between interpolated target 
fluxes. 
For every input of controller 
metabolites, there should be a single 
output for the target flux (this is the 
definition of a mathematical function) 
if those metabolites are the only 
variables that interact with the 
reaction. 
Surface fit Fit a plane surface to the data of the two 
controller metabolite concentrations and 
the target flux and calculate the root 
mean square error of the fit against the 
data. 
Because an existing interaction must 
maintain “functionality,” the controller 
metabolite and target flux data should 
form some sort of surface. There will 
likely be a better fit when fitting a 
plane to data from an existing 
interaction than data from a non-
existing interaction. 
Flux prediction Same as flux prediction feature for 1-
controller metabolite interactions, 
except two metabolites are used to train 
and test the kNN model.  
Same as flux prediction feature for 1-











Plot one of the putative controller 
metabolites (x-axis) against the target 
flux (y-axis) for each of the fifteen 
datasets. Next, plot ten vertical lines that 
are evenly-spaced within the range of 
the controller metabolite that represent 
ten constant concentrations. For one 
vertical line, identify if and where the 
line intersects with the fifteen data sets 
using the InterX function and linearly 
interpolate flux data at these intersection 
points using the closest higher and lower 
concentrations with sampled flux data. 
Calculate the Spearman correlation 
between the second controller 
metabolite and interpolated target flux at 
these intersection points where the first 
controller metabolite is constant. Repeat 
for each of the ten vertical lines and 
calculate the mean of all correlations. 
Switch which metabolite is held 
constant and repeat the process. Take 
the lesser of the absolute values of the 
two mean correlations. 
The correlation between one controller 
metabolite and target flux should be 
consistently close to +1 (activation) or 
-1 (inhibition) for any constant 
concentration value for the second 
metabolite. This assumes no high 
concentration effects, such as substrate 
inhibition. The lesser of the two 
absolute mean correlations is taken as 
it is the worst performing. 
Curve fit with one 
metabolite constant 
Plot one of the putative controller 
metabolites (x-axis) against the target 
flux (y-axis) for each of the fifteen 
datasets. Next, plot ten vertical lines that 
are evenly-spaced within the range of 
the controller metabolite that represent 
ten constant concentrations. For one 
vertical line, identify if and where the 
line intersects with the fifteen data sets 
using the InterX function and linearly 
interpolate flux data at these intersection 
points using the closest higher and lower 
concentrations with sampled flux data. 
Fit a second-order polynomial to the 
second controller metabolite and target 
flux data at these intersection points and 
calculate the root mean square error 
between the fit and the data. Repeat for 
each of the ten vertical lines and 
calculate the mean of all errors. Switch 
which metabolite is held constant and 
repeat the process. Take the greater of 
the absolute values of the two mean 
errors. 
If one controller metabolite is 
constant, a simple polynomial on the 
second controller metabolite and target 
flux should fit well, similar to the 
curve fit feature for 1-controller 
metabolite interactions. The greater of 
the two absolute mean errors is taken 






Table 4 (continued) 
3-controller metabolite interaction features 
Feature name Description Reasoning for feature 
Hyperplane fit Fit a hyperplane to the data of the three 
controller metabolite concentrations and 
the target flux and calculate the root 
mean square error of the fit against the 
data. 
Same as surface fit feature for 2-




For any two datasets generated from 
different initial conditions, find 
concentrations where the three putative 
controller metabolites are within 5% 
(noiseless) or 10% (noisy) across 
datasets. Calculate the CoV of the target 
flux for the two datasets at these points. 
Same as functionality feature for 2-
controller metabolite interactions. 
Flux prediction Same as flux prediction feature for 1-
controller metabolite interactions, 
except three metabolites are used to 
train and test the kNN model.  
Same as flux prediction feature for 1-
controller metabolite interactions. 
Functionality 
(rounding method) 
For any two datasets generated from 
different initial conditions, find 
concentrations where the three putative 
controller metabolites are equal across 
datasets after rounding to the second 
decimal place. Calculate the percent of 
target flux values that are equal (within 
0.002 error). The majority of 
metabolites in this work had mean 
concentrations on the order of 10-1 to 
101, and the majority of fluxes had mean 
rates on the order of 10-2 to 102, making 
the chosen rounding precision and error 
threshold reasonable for this feature. 
Same as functionality feature for 2-
controller metabolite interactions. In 
this feature, the parameters used to 
determine equivalence (i.e. rounding 
precision and error threshold) are fixed 
and are not proportional to the 
concentration or flux data used, unlike 
in the percentage method. This 
difference allows the rounding method 
to be more sensitive when determining 
equivalence for concentration or flux 
data that have larger orders of 
magnitude (i.e. greater concentrations 
and fluxes will be considered equal in 
fewer cases than in the percentage 
method; if they are considered equal, it 
will be with higher confidence). The 
number of decimal places and error 
bounds can be adjusted depending on 




Same as correlation with one metabolite 
constant, except two metabolites are 
held constant and the Spearman 
correlation between the third metabolite 
and target flux is calculated. 
Same as correlation with one 
metabolite constant. 
 
2.2.7 Scaling of feature matrices 
When assessing SCOUR’s performance on noiseless data, we found that the 
feature matrices did not require any scaling because the range of values across features 




training and testing feature matrices significantly improved SCOUR’s performance on 
noisy datasets. Each feature in the feature matrices for two- and three-controller 
metabolites were scaled between 0 and 1. When scaling data in the one-controller 
metabolite feature matrices between 0 and 1, we found poor performance due to a high 
sensitivity to outliers in a few of the one-controller metabolite features. To solve this 
problem, we scaled the feature matrices for one-controller metabolite interactions so that 
the 20th and 80th percentiles of the data were scaled between 0 and 1, which diminished 
the effect of outliers on the machine learning algorithms. This technique is called robust 
scaling90. 
 
2.2.8 Machine learning stacking 
 Stacking is a technique used in machine learning to aggregate predictions made 
by multiple classification or regression algorithms91. The idea behind stacking is that 
some algorithms will be able to classify certain samples better than others, such that by 
combining information from multiple algorithms one can more accurately classify 
samples overall. In SCOUR, we used four machine learning algorithms in a stacking 
model. 
 To train the four algorithms in the first layer of the stacking process, an initial set 
of autogenerated data with known training labels was used for each algorithm. To train 
the metamodel in the second layer of the stacking process, a second set of autogenerated 
data  was passed through the previously trained first layer models and the prediction 
outputs from the four original machine learning algorithms were used as inputs to train 




data. For this work, we chose to use a discriminant analysis classifier as the metamodel, 
as it was shown to perform well in consolidating information from the four algorithms in 
the first layer. A workflow of the stacking process is shown in Figure 4.  
  
 
Figure 4: Workflow of stacking process. 
After the feature matrix is calculated for all possible regulatory interactions, it is used on 
the first level of the stacking process as input for the four machine learning algorithms. 
The four resulting predictions are then used in the second level metamodel to produce a 
final prediction output for the framework. 
 
2.2.9 Machine learning algorithms 
 The four machine learning algorithms used in the stacking model are random 
forest92, k-nearest neighbors (kNN)93, 94, shallow neural networks95, and discriminant 
analysis96. Each of these algorithms are some of the most robust and commonly used 
machine learning approaches, but they are all fundamentally very different from one 
another. In SCOUR, we use kNN and discriminant analysis as binary classifiers: 
algorithms that can predict only two discrete labels. Random forest and neural networks 
are used as regression algorithms, where both predict continuous values. While most of 
these machine learning methods can be used as either discrete classifiers or regression 
models, we decided to have a mixture of these two types of algorithms because we 




prevent any potential bias toward algorithms that are very similar to one another. In the 
stacking process, the predictions from the four models were used as the input for a 
secondary metamodel (another discriminant analysis classifier) to give a final 
classification output for each regulatory interaction that was tested. 
 
2.2.10 Stepwise approach 
 SCOUR uses a stepwise approach to identify different types of regulatory 
interactions at each step, beginning with the identification of one-controller metabolite 
interactions. First, two training datasets that consist of true positive (controlled by a 
single metabolite) and true negative (controlled by multiple metabolites) interactions are 
autogenerated for the two levels of the stacking model. The features described in Table 4 
are calculated for each interaction in the first autogenerated dataset, which are used to 
train the first level of the stacking model. Next, the second level of the stacking model is 
trained using the feature matrix calculated from the second autogenerated dataset. 
Finally, the completely trained stacking model predicts whether or not each interaction in 
the testing dataset (comprised of the possible one-controller metabolite interactions in the 
system of interest) is controlled by a single metabolite. This process is repeated for 
predicting two- and three-controller metabolite interactions.  
This stepwise approach has two key advantages. First, it allows for completely 
independent classification models and features that can be crafted for specifically 
identifying reactions that are controlled by one, two, or three metabolites. We found that 
developing a one-step platform for predicting multiple classes (i.e. reactions controlled 




machine learning algorithms, such as random forest and neural networks, that can be 
tailored toward multiclass classification. Multiclass classification may have performed 
well if SCOUR was only classifying if a reaction is controlled by one, two, or three 
metabolites. However, because SCOUR is also trying to predict the exact controller 
metabolites that interact with a reaction flux, there is an additional layer of complexity 
that is easier to address with multiple binary classification models. The second advantage 
of using a stepwise approach is that after each step, fluxes whose regulatory status has 
already been identified are removed from consideration in the next step so that there are 
fewer interactions to be tested by the machine learning algorithms. This reduces the 
computation time of the entire stepwise process, reduces the chances of false positives, 
and allows subsequent steps and features to be more simply designed under the 
assumption that lower-order regulatory interactions will not be present in later steps. 
However, these advantages are at the risk of removing fluxes at a step earlier than when 
their true regulatory status could be identified. A comparison of the number of 
interactions that need to be tested whether or not the stepwise framework is used for each 
of the evaluated models can be found in Table 3. A schematic of SCOUR’s workflow is 






Figure 5: Workflow of stepwise machine learning framework for identifying one-, 
two-, and three-controller metabolite interactions. 
Blue circles and arrows represent metabolites and the fluxes they might interact with, 
respectively, in the training set. Orange circles and arrows represent metabolites and the 
fluxes they might interact with, respectively, in the testing set. In each step, the training 
set is used to train the machine learning classifier for fluxes with a specific number of 
metabolite controllers, which is then applied to the testing set to predict which fluxes are 
in that category. Between each step of the workflow, fluxes that have been positively 




2.2.11 Framework performance metrics 
 To assess the performance of our framework in identifying different types of 
regulatory interactions, we evaluated four different metrics: accuracy, sensitivity, 
specificity, and positive predictive value (PPV). Accuracy is the percent of candidate 
regulatory interactions that are identified correctly as existing or not existing in a model. 
While accuracy can be a good metric if the classes (i.e. candidate interactions that are 
truly in the model vs. candidate interactions that are not in the model) are well-balanced, 
this is not the case for combinatorial consideration of potential metabolic regulatory 
interactions: there are many more candidate metabolite and reaction flux combinations 
than there are actual regulatory interactions in a given biological system. Sensitivity and 
specificity separate accuracy into two metrics that measure, respectively, the percent of 
positives (i.e. true regulatory interactions) that are identified correctly and percent of 
negatives (i.e. candidate regulatory interactions that are not actually in the model) that are 
identified correctly. PPV is the percentage of interactions predicted by the model that are 
true positives, an important metric to consider when one plans on experimental validation 
of predictions because it indicates how much effort is typically required for the validation 
of every newly discovered interaction. Exceedingly low PPVs are undesirable for 
predictions that are difficult to experimentally test, including metabolite-dependent 
regulation of reaction rates, because they signify that a large number of predicted 
interactions must be tested with these difficult experimental methods in order to find any 







2.3.1 Performance on noiseless data  
When evaluating SCOUR on noiseless data, we found good overall predictive 
accuracy for both synthetic models (Figure 6A and Figure 6B). We trained SCOUR on 30 
independent sets of noiseless autogenerated data to assess the sensitivity of the 
framework to different sets of autogenerated training data. The average sensitivities and 
specificities for all steps in SCOUR were above 88% for both models. PPVs were above 
77% for predicted one- and two-controller metabolite interactions, and above 58% for 
predicted three-controller metabolite interactions.  
 We found similar results when testing SCOUR on noiseless data simulated from 
the E. coli and S. cerevisiae systems (Figure 6C and Figure 6D). As in the synthetic 
models, the PPV for both of these biological models decreased as the number of 
controller metabolites increased, though in a steeper fashion likely due to the increased 
complexity of these systems. The accuracy, sensitivity, and specificity in both biological 
models were still above 71% for all steps, and the PPVs for one- and two-controller 
metabolite interactions were all above 32%, despite the increase in model complexity. 
The low PPV for identification of three-controller metabolite interactions for both 
biological models (< 8%) despite high specificity (> 85%) was attributable to the highly 
imbalanced nature of the testing data. Out of the large number of candidate three-
controller metabolite regulatory interactions that must be classified (Table 3), only a few 
are true positives and consequently there is an increased likelihood for false positive 
predictions. We note the large standard error of the mean for sensitivity in the E. coli 




removing the fluxes of the two true positive interactions in a previous step, which leads to 
the sensitivity not being calculated in several of the repetitions (due to the absence of any 
true positives or false negatives). 
 
   
Figure 6: SCOUR performance on synthetic and biological models using noiseless 
training and test data. 
Bar graphs for accuracy, sensitivity, specificity, and PPV for each step of SCOUR in 
each tested model. Error bars represent the standard error of the mean (n = 30 from 
independent autogenerated training replicates). 
 
 
2.3.2 Performance on noisy data 
While using noiseless data gives a sense for the framework’s performance under 




lead to significant deviation from these idealized assumptions. To assess SCOUR’s 
performance under more biologically relevant conditions, we examined two factors that 
need to be considered when using real metabolomics and fluxomics data: decreased 
experimental sampling frequency (and thus less information content to enable 
identification of true regulatory interactions) and increased experimental measurement 
noise. To give SCOUR a baseline performance level to compare to, we also created a 
classifier that randomly predicted whether a metabolite-flux interaction was a true 
positive or true negative interaction and used this to calculate a PPV at each step. Each 
interaction had a 50% chance of being classified as either a true positive or true negative 
in each step of the framework. For this random predictor, we assumed that the correct 
reaction fluxes were removed at each step, giving this classifier an advantage over our 
framework by greatly reducing the number of possible false positive interactions. 
Assessment of SCOUR’s performance on noisy data from the synthetic models 
(Figure 7A through Figure 7F) yielded similar trends to the results from noiseless data 
(Figure 6A and Figure 6B). For both decreased sampling frequency and increased 
experimental noise, SCOUR’s overall accuracy unsurprisingly decreased, but still 
allowed for effective identification of many regulatory interactions in each model. In both 
synthetic models, there was an expected decrease in sensitivity and PPV with decreasing 
sampling frequency or increasing noise. As in the noiseless case, the PPV decreased for 
fluxes with more controller metabolites due to the increase in candidate regulatory 
interactions (and thus, an increase in possible false positive predictions) tested at each 
stage. In the most experimentally realistic scenario (nT = 15, CoV = 0.15), SCOUR still 




controller metabolite interactions (> 59% and > 18%, respectively). The mean PPVs for 
one- and two-controller metabolite interactions were also better than the random 
predictor in both synthetic models across all conditions and SCOUR outperformed the 
random predictor in most cases when classifying three-controller metabolite interactions. 
 The results from testing on biological models with noisy data (Figure 7G through 
Figure 7L) were similar to those from the synthetic models (Figure 7A through Figure 
7F). For both the S. cerevisiae and E. coli models, the PPV was fairly consistent (with 
slight decreases) for any given interaction type across the increasingly challenging noisy 
conditions, while accuracy, sensitivity, and specificity sometimes exhibited slightly more 
variability across those conditions. For the S. cerevisiae model, the PPV remained high 
(> 69% on average) in all conditions for identification of one-controller metabolite 
interactions and was above 25% for identification of two-controller metabolite 
interactions. These PPVs for one- and two-controller metabolite interactions are 
sufficiently high enough if one wanted to experimentally validate these predictions to 
identify previously unknown interactions. For three-controller metabolite interactions, the 
PPV was below 12% for all conditions, which is not ideal from the standpoint of 
experimental practicality. In the E. coli model, the accuracy, sensitivity, specificity, and 
PPV were high for one-controller metabolite interactions in all conditions (> 92%), but 
the PPV dropped to less than 13% for two-controller metabolite interactions and was 
essentially 0% for three-controller metabolites (and a large standard error of the mean for 
sensitivity was observed, as in the noiseless condition in Figure 6D). This would make it 
challenging to experimentally validate the E. coli predictions for two- and three-




Nevertheless, the PPVs for both biological systems when using SCOUR were on average 
better than the PPVs of the random predictor for one- and two-controller metabolite 
interactions for all conditions. 
    
 
Figure 7: SCOUR performance on synthetic and biological models using noisy and 
low sampling frequency training and test data. 
Solid lines represent accuracy, sensitivity, specificty, and PPV performance of SCOUR 
on each model for each step of the framework. Dashed lines represent the PPV if 
interactions were randomly classified. Error bars represent the standard error of the mean. 




Our results indicate that SCOUR is a promising route for in silico prediction of 
metabolite-dependent regulation of metabolic fluxes using metabolomics and fluxomics 
data. On noiseless data, SCOUR predicts one- and two-controller regulatory interactions 




also predicted extremely well in some systems. While the use of noisy data leads to an 
expected drop in performance, SCOUR still provides extremely high PPV for one-
controller interactions in all systems and high (experimentally useful) PPV for the 
synthetic models and the S. cerevisiae model when predicting two-controller metabolite 
interactions. SCOUR’s PPVs for these two steps greatly outperformed the PPVs of a 
random classifier in almost all cases. PPVs for three-controller metabolite interactions 
remained useful for the synthetic models but pushed the bounds of practical utility in the 
S. cerevisiae and E. coli models, likely attributable in large part to the combinatorial 
growth of the number of candidate interactions that must be tested and thus the 
concomitant growth in the number of false positives. Regardless of whether the three-
controller interaction predictions are sufficient for experimental validation, the PPV in 
the S. cerevisiae model is significantly greater than the PPV for random classification for 
all noisy conditions except for the lowest sampling frequency and highest noise case 
(Figure 8). This suggests that SCOUR would still be helpful for identifying these types of 
interactions compared to indiscriminately testing all combinations of interactions as high-





Figure 8: SCOUR’s PPV for 3-controller metabolite interaction predictions is 
significantly greater than a random classifier. 
While SCOUR yields low PPVs in the S. cerevisiae model for 3-controller metabolite 
interactions, these results are significantly better than random classification of 3-
controller metabolite interactions for all conditions except for the case with the fewest 
timepoints and most noise (nT = 15, CoV = 0.15). We used a Wilcoxon rank-sum test 
(alpha = 0.05) to assess significance, as we found the distributions of the PPVs from 
SCOUR were not normal when using a Kolmogorov-Smirnov test (alpha = 0.05), except 
for the nT = 50, CoV = 0.05 condition. With appropriate guided high-throughput 
methods, SCOUR’s predictions could still be useful for identifying these types of 
reactions. 
 
 We believe the unusually sharp decrease in PPV for the E. coli model between the 
one- and two-controller interaction predictions is largely attributable to two reasons. 
First, the E. coli model contains three two-controller metabolite interactions where the 




Figure 9). This presents an identifiability problem, with it being extremely difficult to 
decouple the effects of the two metabolites once even a small amount of noise is added to 
their data. This in turn affected the utility of several features in our machine learning 
models, which led to these three interactions rarely being identified by SCOUR and thus 
also led to lower sensitivities and PPVs. Second, as previously discussed, the large size of 
the E. coli model necessitates testing many candidate regulatory interactions. Even with 
relatively high specificity, the resulting false positives from these tests can suppress the 
PPV. This is a common problem found in other efforts to determine regulatory activity 
(or any work with imbalanced datasets), where one class (e.g. true negative interactions) 







Figure 9: The most common false negative two-controller metabolite interactions in 
the E. coli model. 
Three two-controller metabolite interactions were not correctly predicted across many 
conditions and replicates. The metabolites involved in these three interactions were 
highly correlated with each other, as indicated by these plots of noiseless concentration 
data for each of the pairs of metabolites. Each of the fifteen datasets with different initial 
conditions is represented by a different group of colored data. The scatter plots indicate 
extremely high correlation, which mitigated the utility of some of the features provided to 
the machine learning models (e.g. functionality and flux prediction). Inclusion of such 
interactions with highly correlated controller metabolites in the autogenerated data did 
not improve SCOUR’s ability to identify these metabolites, especially once noise was 
introduced into the measurements. 
 
 Throughout the evaluation of SCOUR, we have relied on PPV as a performance 
metric because it is a valuable indicator for whether or not the predictions by SCOUR are 
worth experimentally validating. F1 score is another performance metric that is calculated 
from PPV and sensitivity and it is often used for imbalanced datasets, such as those found 
in this work. When using F1 score, we found that SCOUR still outperformed random 
classification of one- and two-controller metabolite interactions in all models under all 
noisy conditions evaluated (Figure 10). For three-controller metabolite interactions, the 




we would once again conclude that it would be difficult to recommend lab validation of 
the predictions for these types of interactions without high-throughput guided methods. 
While F1 score is an important evaluation metric and still verifies that SCOUR is a useful 
platform for identifying one- and two-controller metabolite interactions, we argue that 
PPV is a more important criterion in the context of finding new regulatory interactions 
because it indicates how many undiscovered interactions could be identified out of those 
predicted by SCOUR, regardless of how many true positive interactions exist. 
 
 
Figure 10: F1 scores for synthetic and biological models using noisy and low 
sampling frequency training and test data. 
Bold lines represent the average F1 scores of SCOUR and dashed lines represent the 
average F1 scores when randomly classifying interactions (n = 30 from independent 
autogenerated training replicates). Note that the F1 score does not exist when identifying 
three-controller metabolites in the E. coli model for two conditions (nT = 50, CoV = 0.05 
and nT = 15, CoV = 0.05) because SCOUR had removed both of the true positive three-
controller metabolite interactions in a previous step of the framework for all repetitions, 




 Perhaps the most striking feature of SCOUR is its use of the autogeneration of 
synthetic interactions for training data. Because machine learning models generally 
require large amounts of data for training, and because this scale of data is typically not 
available for metabolomics and fluxomics data, we created a method to automatically 
generate training data that are in some way representative of a wide variety of real 
biological interactions. While these autogenerated “interactions” may not perfectly 
recapitulate the data that result from real reactions, SCOUR’s success shows that this 
autogeneration method can sufficiently train machine learning algorithms to identify 
regulatory interactions in many different systems. Because dynamic metabolomics and 
especially fluxomics data are so expensive and difficult to acquire with current analytical 
tools, this autogeneration method may prove useful for other tasks that require large 
amounts of these types of data. 
 Although this proof-of-principle framework has demonstrated significant 
potential for identification of many different regulatory interactions, there are several 
potential future avenues to improve overall performance. We note that both training and 
testing on autogenerated data produces higher PPVs (Figure 11), which indicates that the 
autogenerated data do not perfectly capture biological interactions. Autogeneration of 
training data using Michaelis-Menten or other kinetics equations instead of BST 
equations could improve machine learning performance by generating training data that 
are more representative of the types of kinetics encountered in biological systems. While 
we chose to initially use BST equations for autogeneration based on their simplicity and 







Figure 11: SCOUR performance when training on autogenerated data and testing 
on autogenerated testing data. 
Testing data was autogenerated in a similar manner as the training data, but the 
percentage of true positive three-controller metabolite interactions in the testing set was 
set to 1% to more closely resemble the percentages found in the synthetic and biological 
models assessed (Note: training SCOUR with 1% instead of 5% true positives did not 
seem to help performance). The results when testing on autogenerated data were better 
than when testing on the synthetic or biological models, which is likely due to the testing 
data more closely resembling the training data because both datasets were autogenerated. 
Because we observe a similar decrease in PPV (when testing on the synthetic and 
biological systems) as the number of controller metabolites increases, this increase in 
performance when testing on autogenerated data is not likely completely due to 
overfitting, or else we would expect to see consistently high performance across all steps 
of the framework. The autogenerated training data has shown to be effective in 
classifying many interactions in the synthetic and biological models, and improvements 
to this autogeneration method or the integration of biological data will only lead to better 
performance with SCOUR. 
 
 
 Second, as in all machine learning approaches, there is room to improve the 
features used to help predict true interactions. We designed knowledge-driven features 
based on how metabolites interact with the reaction fluxes they control. Data-driven 
features derived from raw metabolomics and fluxomics data could be beneficial if there 
are sufficient data to drive the derivation of these features, including the underlying 
“ground truth” about whether a given interaction truly exists in a system. Such features 




metabolites and fluxes are connected to each other, which has previously been used in 
metabolic contexts98, 99. However, an outstanding challenge will be how to include 
autogenerated data that are representative of these topological trends and capture the 
biological intricacies of metabolic systems, given that the autogenerated data are by 
definition synthetic and at least partly non-biological in nature. Additionally, machine 
learning algorithms for input to the stacking model beyond those tested here could also 
improve SCOUR’s performance. 
 Finally, the preprocessing of noisy experimental data undoubtedly can impact 
downstream analytical performance. While we settled on the median sample of the 
triplicate data when calculating features for one-controller metabolite interactions, and a 
Gaussian moving filter to smooth the data for two- and three-controller metabolite 
interactions, we also tried an average moving filter as well as an in-house smoothing 
approach 100. Because the framework mostly produces extremely accurate results on 
noiseless data for all models tested, an improved data pre-processing approach (e.g., 
filtering, normalization, scaling, or other smoothing methods101-103) could significantly 
increase classification performance.  
Notwithstanding these potential avenues for improvement, SCOUR is already a 
useful tool. At the very least, SCOUR can determine with high confidence reaction fluxes 
that are only controlled by a single metabolite, eliminating swaths of the metabolic 
network where metabolite-dependent regulation is unlikely to occur. However, SCOUR 
can also identify many more complex interactions, including possibly pointing towards 





Figure 12: Four-controller and higher-order metabolite regulatory interactions.  
While we only focus on classifying one-, two-, and three-controller metabolite 
interactions, SCOUR may still provide information about four-controller or higher-order 
metabolite interactions. After removing the fluxes with predicted regulatory relationships 
in the three described steps of the framework, we have found that there is some evidence 
supporting the identification of leftover fluxes in the A) S. cerevisiae and B) E. coli 
models as being controlled by four metabolites. The two models contain 2 and 4 four-
controller metabolite interactions (red bars), respectively. While the framework is unable 
to identify the controller metabolites that interact with these fluxes, being able to predict 
which fluxes are controlled by more than three metabolites may be useful for 
understanding reaction mechanisms. Further improvements to the accuracy in each of the 
steps of the framework would be required to ensure that the majority of fluxes that 





SCOUR is a proof-of-principle for how metabolomics and fluxomics data can be 
leveraged with machine learning to find metabolite-dependent regulatory interactions; to 
our knowledge, this is the first reported example of such an approach. The identification 
of metabolite-dependent regulatory interactions has to date been critically hampered by 
experimental limitations in measuring and validating these interactions, making 
SCOUR’s predictions and triaging particularly valuable for such labor-intensive 
endeavors. Enabled by a method for autogenerating training data that reasonably mimic 
data from real biological systems, SCOUR circumvents the requirement for massive 
training sets that is typically associated with machine learning approaches. While 
metabolomics and fluxomics data are often collected at putative steady states, it is quite 
feasible to collect these data dynamically to leverage SCOUR’s potential for biological 
discovery. This means that as analytical methods for measuring metabolomics and 
fluxomics become cheaper and easier, and more data are available for analysis, SCOUR 






CHAPTER 3: Inferring Absolute Concentrations from Relative 





Since its inception, metabolomics has been used in a wide variety of applications, 
including identification of disease biomarkers, disease diagnosis, and even drug 
development15, 104. While genomics, proteomics, and transcriptomics provide an upstream 
view of cellular function and information about what may occur in a system, 
metabolomics is a direct readout of a system’s current metabolic state and has emerged as 
an important area of study for understanding what is actually occurring in a system 105. 
As the systems-scale study of metabolites, metabolomics has the potential to be 
integrated into metabolic modeling frameworks to better understand how cellular systems 
function and react to endogenous or exogenous perturbations25. In order to develop 
accurate metabolic models, an ample amount of metabolomics data will be necessary.  
As described at the beginning of this thesis, researchers commonly use three 
analytical techniques to measure metabolomics: nuclear magnetic resonance (NMR) 
spectroscopy and gas and liquid chromatography-mass spectrometry (GC-MS and LC-
MS, respectively). Because NMR is significantly less sensitive than GC-MS and LC-MS, 
many researchers turn to mass spectrometry when measuring hundreds or thousands of 
metabolites at low concentrations in a single sample29. LC-MS is able to detect more 
metabolites than GC-MS and does not require any sample derivatization3, 27, but GC-MS 
still remains popular among researchers due to its relative inexpensiveness compared to 




The greatest weakness of these mass spectrometry approaches is quantification107, 
as the metabolomics data resulting from using these instruments are typically relative 
abundances and not absolute concentrations. These relative abundances still allow for 
some types of analysis, including principal component analysis (PCA)108 and t-tests, as 
relative abundance measurements of the same analyte can be compared from sample to 
sample. However, comparing the relative abundances of different metabolites has no 
quantifiable meaning109. Even if two metabolites have similar absolute concentrations, 
their peaks on a chromatogram and therefore their relative abundances can be radically 
different because of how chemicals with different structures and properties are 
derivatized, ionized, or fragmented32, 110. Similarly, peaks with comparable intensities do 
not necessarily imply equal absolute concentrations. This precludes the use of raw 
metabolomics data in many computational tools used to study metabolism. For example, 
several metabolic modeling platforms, such as MetDFBA, TMFA, and LK-DFBA56, 111, 
112 can directly integrate metabolite data into their frameworks, but they all require 
absolute concentrations. 
Many researchers use chemical standards in mass spectrometry to quantify 
metabolites. However, these standards can be costly, time consuming to use, and 
unavailable for certain metabolites30-32. Using standards may only be feasible for 
quantifying a few metabolites, but for the purposes of untargeted metabolomics, where 
one attempts to measure all metabolites113, it quickly becomes infeasible. Untargeted 
metabolomics data is restricted to being used with only the most exploratory 
computational tools, like PCA, for semi-quantitative analysis109. A method for 




the usability of metabolomics data in computational tools and would be incredibly 
beneficial to the metabolomics community.  
As one of the most critical challenges preventing metabolomics from being more 
readily used in wider applications, there have previously been efforts attempting to 
quantify metabolomics data without chemical standards. Much of this work has focused 
on predicting ionization efficiencies of different chemicals, which is directly linked to the 
relative abundance output of a chromatogram in mass spectrometry. It has been shown 
that intrinsic thermodynamic properties, electrokinetic properties, structural properties, 
and solvent factors are all key factors that contribute to the prediction of ionization 
efficiencies114, 115. Recently, Liigand et al. developed a method for predicting ionization 
efficiencies using random forest machine learning116. Another recent approach is 
MetabQ, a calibration curve-free method for quantification of polar metabolites117. While 
MetabQ still requires chemical standards, they only need to be used once in the lifetime 
of an instrument to determine the relationship between relative abundances and absolute 
concentrations. 
 In this work, we have developed a new computational framework for inferring the 
most likely absolute concentrations from relative abundance metabolomics data for 
cellular metabolism, which we have named Metabolomics Prediction of Absolute 
Concentrations (MetaboPAC). MetaboPAC attempts to avoid the need for chemical 
standards by leveraging the mass balances of a metabolic system and determining the 
most biologically likely metabolic profiles. To the best of our knowledge, this is the first 
computational platform for standard-free inference of absolute concentrations using 




ability to readily integrate metabolomics data with metabolic modeling and other 
metabolic analysis tools in the future. 
 
3.2 Methods for Inferring Absolute Concentrations 
3.2.1 Synthetic models 
 To assess MetaboPAC on different types of possible metabolic systems, we 
created two synthetic models. The first synthetic model (Figure 13A) contains four 
metabolites and five fluxes, where the initial influx is a known, constant reaction rate. 
With four metabolites and four unknown fluxes, the system is determined, which allows 
for the fluxes to be trivially solved using Equation 4, where 
𝑑?⃑?
𝑑𝑡
 is the vector of the change 
in concentration over time for each metabolite, S is the stoichiometric matrix of the 
system, and ?⃑? is the vector of fluxes. Since a determined system typically has a single 





= 𝑆 ∙ ?⃑?  (Equation 4) 
 
 The second synthetic model (Figure 13B) contains four metabolites and eight 
fluxes. Once again, the influx is assumed to have a known, constant reaction rate. Unlike 
the determined model, the second model contains more unknown fluxes than metabolites 
and is therefore underdetermined. Furthermore, we have included two allosteric 
regulatory interactions, inhibiting flux v3 and promoting flux v8. Most biological systems 




complex and more relevant test for MetaboPAC. Both synthetic systems were constructed 
using Michaelis-Menten kinetics to model each reaction and each system was simulated 
for 10 seconds to generate concentration and flux data. 
 
 
Figure 13: Synthetic systems tested with MetaboPAC. 
We built one determined synthetic system and one underdetermined synthetic system 
with regulation using Michaelis-Menten kinetics for each reaction. xi represents the ith 
metabolite and vj represents the jth flux. In both systems, flux v1 is assumed to be constant 
and known.  
 
 
3.2.2 Biological models 
 While synthetic models are pragmatic for initially developing and testing 
MetaboPAC, they do not sufficiently resemble biological models to allow generalization 
of initial results to later applications. To further evaluate the robustness of MetaboPAC, 
we examined models of Escherichia coli44 and Saccharomyces cerevisiae47 metabolism. 
Both of these systems are underdetermined and include numerous allosteric regulatory 
interactions, with the E. coli model containing 18 metabolites and 48 fluxes, and the S. 




for both models include a mixture of Michaelis-Menten, Hill, and mass action kinetics. 
Data for both biological systems were produced by reconstructing the ODE models in 
MATLAB and simulating the E. coli and S. cerevisiae models over 10 seconds and 300 
seconds, respectively.  
 
3.2.3 Response factors 
To emulate relative abundance data, we generated 20 sets of response factors for 
each metabolite found in the four systems evaluated in this work. Response factors 
describe the relationship between relative abundances and their absolute concentrations. 
Each response factor was randomly selected from a uniform distribution between 1 and 
1000. These sets of response factors (RFT) were multiplied by the true absolute 
concentration values simulated by the kinetic models to calculate the relative abundances, 
assuming there is a direct linear relationship between the two (Equation 5). While this 
relationship is not always linear, calibration curves using chemical standards are often 
calculated using the slope of the curve and cover the linear dynamic range of an 
instrument for a particular analyte118. Additionally, metabolite responses are typically 
linear over two to four orders of magnitude32, 119, making it reasonable to assume a linear 
relationship between relative abundances and absolute concentrations. To infer absolute 
concentrations, the relative abundances are divided by the response factors predicted by 
MetaboPAC. The absolute concentrations for the systems used in this work ranged from 
1e-4 mM to 20 mM. 
 




3.2.4 Kinetic equations approach 
If the kinetic rate law of each reaction in the system has been previously 
determined, the mass balances of the system and dynamic nature of time course 
metabolomics data can be leveraged to identify the response factors necessary to infer 
absolute concentrations. Based on the mass balances, the rate of change in concentration 
of a metabolite must always equal the sum of stoichiometrically balanced influxes and 
effluxes of the metabolite (Equation 4). When the kinetics of the reaction fluxes are 
known, each influx and efflux can be represented by a mathematical term containing 
kinetic parameters and the concentration of the metabolite(s) that participate in the 
reaction, either as a substrate or an allosteric regulator. Because only relative abundances 
and not absolute concentrations are available, the metabolite concentrations in these 
kinetic equations are replaced by their respective relative abundances divided by a 
response factor. The rate of change can be determined by calculating the difference in 
relative abundance at two subsequent timepoints and dividing by the change in time. 
Once again, the relative abundances in these rate of change calculations are divided by a 
response factor to infer absolute concentrations.  
Across different timepoints in the metabolomics dataset, the response factors 
should remain constant for each metabolite, as they are not expected to change 
throughout an experiment. Together, the mass balances at each timepoint create a system 
of non-linear equations. A non-linear least-squares solver can determine the set of 
response factors that minimizes mass balance violations. These systems of equations 
must be determined or overdetermined to use the non-linear least-squares solver; as the 




system of equations decreases. In the kinetic equations approach, this system of non-
linear equations is solved 48 times (chosen based on the maximum number of local 
workers (12 workers, each used 4 times) when performing parallel computations) with 
different initial seeds selected from a uniform distribution and the medians of the 
predicted response factors are calculated at the conclusion of all the runs as the most 
likely set of response factors. 
 
3.2.5 Optimization approach 
 It is not uncommon for the kinetic equations of a reaction to be unknown, 
especially if the reaction is not in the most studied pathways of metabolism, such as 
central carbon metabolism. Instead of relying completely on the mass balances of the 
system to determine response factors, the optimization approach creates a minimization 
problem to predict the most likely set of response factors. In addition to minimizing mass 
balance violations in Equation 4 (without the known kinetic equations of the fluxes), 
there are also several penalties that can be added to the objective function to help identify 
sets of response factors that are biologically likely (Table 5). These penalties eliminate 
sets of response factors that lead to absolute concentrations that are biologically 
infeasible. For example, if a metabolite is the sole substrate of an enzyme, we expect the 
reaction rate to increase as the concentration of the metabolite increases. If this 
interaction is not observed between the inferred absolute concentration of the metabolite 
and the flux, the set of response factors would be heavily penalized. As in the kinetic 




seeds and the medians of the predicted response factors from all the runs is calculated to 
determine the most likely set of response factors. 
Table 5: Penalties used in the optimization approach of MetaboPAC 
Penalty Description Reasoning 
Mass balance Calculate the sum of squared 
residuals between the inferred 
change in absolute concentration 
over time calculated from the 
raw relative abundance data (i.e. 
the change in relative abundance 
over time divided by the 
predicted response factor) and 
the inferred change in absolute 
concentration over time 
calculated from the 
stoichiometry of the system and 
inferred fluxes (i.e. Equation 4). 
If the change in absolute 
concentration over time is vastly 
different between the two 
calculations (i.e. the sum of 
squared residuals is greater than 
zero), the predicted response 
factors have failed to produce 
inferred absolute concentration 
and flux profiles that do not 
violate any mass balances in the 
system. 
Maximum concentration If the inferred absolute 
concentration for any metabolite 
is above 5 mM or 50 mM for 
synthetic and biological systems, 
respectively, add a penalty equal 
to the maximum value of all 
inferred concentrations. 
It is reasonable to assume that 
for many metabolites, there can 
be a general estimate for a 
maximum concentration that is 
biologically feasible, either due 
to limits in production or cell 
toxicity. Here, we use a single 
threshold for all metabolites, but 
imposing individual maximum 
thresholds would lead to better 
response factor predictions.  
Correlation for mass action 
reaction with a single substrate 
Calculate the correlation 
between the controller 
metabolite and inferred target 
flux. The correlation is expected 
to be positive (because 
metabolites induce mass action 
reactions), the penalty for each 
one-controller metabolite 
reaction equals the calculated 
correlation minus one.  
If a reaction is only controlled by 
a single metabolite, the reaction 
rate should either increase or 
decrease as the concentration of 
the metabolite increases 
(assuming the kinetics of the 
reaction do not exhibit any 
behavior similar to substrate 
inhibition). 
Curve fit for mass action 
reaction with a single substrate 
Calculate the fit of a second-
order polynomial to the 
controller metabolite and target 
flux data. The penalty for each 
one-controller metabolite 
reaction equals one minus the 
adjusted R2 of the fit (adjusted 
for the number of coefficients). 
A second-order polynomial 
should fit the data reasonably 
well if a reaction is controlled by 
a single metabolite (e.g. if the 








Table 5 (continued) 
Correlation for reactions 
regulated by two controller 
metabolites 
Plot the data of one of the 
controller metabolites (x-axis) 
against the data of the inferred 
target flux (y-axis). Next, plot 23 
vertical lines that are evenly 
spaced within the range of the 
controller metabolite that 
represent 23 constant 
concentrations. For one vertical 
line, identify if and where the 
line intersects with the data 
using the InterX function and 
linearly interpolate flux data at 
these intersection points using 
the closest higher and lower 
concentrations with sampled flux 
data. Calculate the Spearman 
correlation between the second 
controller metabolite and 
interpolated target flux at these 
intersection points where the 
first controller metabolite is 
constant. Repeat for each of the 
23 vertical lines and then 
calculate the mean correlation. 
To calculate the penalty, take the 
mean correlation and subtract 
(for metabolites expected to 
induce the reaction) or add (for 
metabolites expected to inhibit 
the reaction) one. Switch which 
metabolite is held constant and 
repeat the process. Finally, sum 
all penalties together. 
The correlation between one 
controller metabolite and its 
target flux should be consistently 
close to +1 (activation) or -1 
(inhibition) for any constant 
concentration value for the 
second metabolite. This assumes 
that a controller metabolite 
cannot switch from inducing to 
inhibiting a reaction (or vice 
versa) at high concentrations, 
such as in substrate inhibition. 
Fit to BST kinetic equations For each reaction in a system, fit 
the inferred absolute 
concentration and flux data to a 
BST equation97 representing the 
reaction rate. Calculate the sum 
of squared residuals of the fit. 
A generic BST kinetic equation 
should fit reasonably well to 
correctly inferred absolute 
concentration and flux data. 
 
3.2.6 Combining the kinetic equations and optimization approaches 
 In many cases, the kinetic equations of the reactions in a system are only partially 
known. In this scenario, the kinetic equations and optimization approaches can be used in 
serial. First, the kinetic equations approach is used for the metabolite mass balance 




few of the kinetic equations of the fluxes in a mass balance are known, it cannot be used 
in the kinetic equations approach; this can be a common occurrence when only a small 
percentage of the kinetic structure of the system is known. Only the response factors 
associated with the metabolites present in the useable mass balances can be identified in 
this step. After predicting all the possible response factors using the kinetic equations 
approach, the optimization approach proceeds as described above, except the response 
factors that have already been identified are fixed within the optimization problem and 









Figure 14: MetaboPAC workflow for inferring absolute concentrations from 
relative abundances in metabolomics datasets.  
In the kinetic equations approach, the mass balances at each timepoint are used to create a 
system of non-linear equations where the response factors in the useable mass balances 
are predicted. These initial predicted response factors are transferred and fixed in the 
optimization approach, where penalties are used to eliminate possible sets of the 
remaining response factors. The final predicted response factors are used to infer the 
absolute concentrations of the data. RAi is the relative abundance and RFi is the unknown 
response factor of the ith metabolite, tn is a particular timepoint in the data, Sxi is the 
stoichiometric mass balance coefficients of the ith metabolite, and vtn is a vector of the 
fluxes at timepoint tn. The kinetic equations (if known) of vtn also contain relative 
abundances and response factors and are as shown in the inset (Michaelis-Menten 




3.2.7 Solving for flux distributions in the optimization approach 
 The only information that MetaboPAC assumes is known is the stoichiometry and 
metabolite-dependent allosteric regulation of the system, the kinetic structure of the 
system (if the kinetic equations approach is used), and the relative abundances of the 




used to calculate some of the penalties that describe the relationship between inferred 
absolute concentrations and the reactions they control. Because fluxomics data are not 
assumed to be available, the fluxes must be inferred by solving Equation 4. As in the 
kinetic equations approach, the rate of change is determined by calculating the difference 
in relative abundance between two timepoints divided by the time difference. This rate of 
change is divided by the corresponding response factor to infer the rate of change of 
absolute concentration for each metabolite. While the fluxes of a determined system can 
be trivially calculated, underdetermined systems have an infinite number of flux 
solutions. To choose a single solution, the optimization approach uses the Moore-Penrose 
pseudoinverse, which minimizes the norm of the flux solution120. If the kinetic equations 
of some of the fluxes are known, they can be used to create a less underdetermined 
system that could possibly be determined or even overdetermined, which would allow a 
unique flux solution to be found.  
 
3.2.8 Noise-added data 
To generate noisy data that more closely represent experimental metabolomics 
data, we used two sampling frequencies and two coefficients of variation (CoV) for 
randomly-added noise, for a total of four conditions. Sampling frequencies of 50 and 15 
timepoints (nT) and CoVs of 0.05 and 0.15 were tested, where a higher CoV represents 
more noise (experimental error). Starting from the data generated by the ODEs defining 
the systems, each concentration value in each metabolomics dataset was replaced with a 
random value drawn from 𝑁𝑖,𝑘 ~ (𝑦𝑖(𝑡𝑘),𝐶𝑜𝑉∙𝑦𝑖(𝑡𝑘)), where 𝑦𝑖(𝑡𝑘) is the value of 




window of one-fourth the length of the simulated time interval. 
 
3.2.9 Evaluation metrics and comparing to baseline methods 
 To measure the performance of MetaboPAC, we calculated the relative difference 
between the true and predicted values of the response factors using a logarithmic scale 
and determined if it was within a range of log2(1.1), log2(1.3), and log2(1.5) error, as 
shown in Equation 6. RFT is the true response factor, RFP is the predicted response factor, 
and x is the value that determine the log2 error range (i.e. 1.1, 1.3, or 1.5). We found that 
using absolute percent error instead of a logarithmic scale could lead to large error ranges 
that would make the evaluation metric less meaningful. For example, 100% error for a 
response factor of 500 would cover a range from 0 to 1000 (i.e. the entire search space of 
response factors for this work), whereas using a logarithmic scale would cover a range 
from only 250 to 1000. The percentages of predicted response factors that were within 
each log2 error range were compared among the methods assessed. 
 
|log2 𝑅𝐹𝑇 − log2 𝑅𝐹𝑃| < log2 𝑥  (Equation 6) 
 
To provide a baseline performance for predicting response factors, we examined 
two other methods for predicting response factors that were compared to MetaboPAC. 
The first method randomly predicts response factors using a uniform distribution between 
1 and 1000 for each metabolite. The second method uses a response factor of 500 for 
each metabolite, as predicted response factors close to the middle of the search space will 




factor if the response factors are chosen from a uniform distribution. 
 
3.3 Results 
3.3.1 MetaboPAC performance on noiseless data 
When initially assessing the performance of MetaboPAC on the two synthetic 
systems, we found the framework to perform exceptionally well on noiseless data (Figure 
15). For all percentages of known kinetic equations, MetaboPAC performed significantly 
better than the random response factors and response factors of 500 for each of the log2 
error ranges examined. For the underdetermined system with regulation, MetaboPAC 
performed significantly better than the other two methods when at least 60% of the 
kinetic equations were known for the log2(1.1) error range and when at least 40% of the 
kinetic equations were known for the log2(1.3) and log2(1.5) error ranges. Unsurprisingly, 
as the percentage of known kinetic equations increased, the accuracy of predicted 
response factors also generally increased for MetaboPAC, with 100% of the response 
factors within the log2(1.1) error range for both systems when 100% of the kinetic 
equations were known. As expected, the response factors predicted when using the 
kinetic equations approach were more accurate than the predictions by the optimization 
approach (Figure 16). Figure 17 shows the mean percentage of response factors predicted 
by either the kinetic equations approach or optimization approach across different 






Figure 15: MetaboPAC performance on noiseless data for synthetic systems. 
MetaboPAC compared to random response factors and response factors of 500 for the A. 
determined and B. underdetermined with regulation systems using error ranges of 
log2(1.1), log2(1.3), and log2(1.5). Lines represent the mean percent of predicted response 
factors within the error ranges for each method. Error bars represent the standard error of 
the mean (n = 20 for different sets of true response factors). Asterisks denote when 
MetaboPAC performed significantly better at predicting response factors than both of the 




Figure 16: Percent of response factors predicted by the kinetic equation and 
optimization approaches within each log2 error range for the synthetic systems 
when using noiseless data. 
The kinetic equations approach generally predicted more accurate response factors than 
the optimization approach. Error bars represent the standard error of the mean (number of 





Figure 17: Percentage of response factors predicted by the kinetic equation and 
optimization approaches for the synthetic systems. 
As the percentage of known kinetic equations increases, it is more likely for response 
factors to be solvable using the kinetic equations approach. Error bars represent the 




 Testing MetaboPAC on the two biological systems with noiseless data yielded 
similar results (Figure 18). For the S. cerevisiae system, MetaboPAC performed 
significantly better than the other two methods across all log2 error ranges when at least 
40% of the kinetic equations were known, except for one case in the log2(1.5) error range. 
In the E. coli system, 60% of kinetic equations were required to be known for 
MetaboPAC to perform significantly better than the other two methods across all log2 
error ranges. Once again, the kinetic equations approach typically outperformed the 
optimization approach (Figure 19). While the performance of MetaboPAC on the 
biological systems was not as high as the performance on the synthetic systems, it was 
still able to predict at least 58.9% of the response factors within log2(1.1) error and at 
least 83% of the response factors within log2(1.3) error in both systems when 100% of the 






Figure 18: MetaboPAC performance on noiseless data for biological systems. 
MetaboPAC compared to random response factors and response factors of 500 for the A. 
S. cerevisiae and B. E. coli systems using error ranges of log2(1.1), log2(1.3), and 
log2(1.5). Lines represent the mean percent of predicted response factors within the error 
ranges for each method. Error bars represent the standard error of the mean (n = 20 for 
different sets of true response factors). Asterisks denote when MetaboPAC performed 
significantly better at predicting response factors than both of the other two methods 




Figure 19: Percent of response factors predicted by the kinetic equation and 
optimization approaches within each log2 error range for the biological systems 
when using noiseless data. 
The kinetic equations approach generally predicted more accurate response factors than 
the optimization approach. Error bars represent the standard error of the mean (number of 





Figure 20: Percentage of response factors predicted by the kinetic equation and 
optimization approaches for the biological systems. 
As the percentage of known kinetic equations increases, it is more likely for response 
factors to be solved using the kinetic equations approach. Error bars represent the 




3.3.2 MetaboPAC performance on noisy data 
While noiseless data provides a good benchmark for the performance of 
MetaboPAC under ideal conditions, real experimental metabolomics data will have some 
degree of noise. To test the robustness of MetaboPAC under more realistic conditions, we 
assessed MetaboPAC on datasets with different sampling frequencies (nT = 50 or 15) and 
different amounts of added noise (CoV = 0.05 or 0.15). In the synthetic systems, 
MetaboPAC was significantly better than both the random and 500 response factor 
approaches for almost all log2 error ranges (Figure 21 and Figure 22) when 100% of 
kinetic equations were known under the low sampling frequency and high noise condition 
(nT = 15, CoV = 015). We also determined that MetaboPAC generally performed the 
best in the conditions with low amounts of noise (CoV = 0.05) and often only required 
60% or 80% of the kinetics to be known to outperform the other methods. As found in the 




accuracy of the optimization approach in most cases (Figure 23 and Figure 24).  
  
Figure 21: MetaboPAC performance on all conditions of noisy data for the 
determined system. 
MetaboPAC compared to random response factors and response factors of 500 for the 
determined system using error ranges of log2(1.1), log2(1.3), and log2(1.5) on data with 
different sampling frequencies (nT = 50 or 15) and noise added (CoV = 0.05 or 0.15). 
Lines represent the mean percent of predicted response factors within the error ranges for 
each method. Error bars represent the standard error of the mean (n = 20 for different sets 
of true response factors). Asterisks denote when MetaboPAC performed significantly 
better at predicting response factors than both of the other two methods (two-sample t-






Figure 22: MetaboPAC performance on all conditions of noisy data for the 
underdetermined system with regulation. 
MetaboPAC compared to random response factors and response factors of 500 for the 
underdetermined system with regulation using error ranges of log2(1.1), log2(1.3), and 
log2(1.5) on data with different sampling frequencies (nT = 50 or 15) and noise added 
(CoV = 0.05 or 0.15). Lines represent the mean percent of predicted response factors 
within the error ranges for each method. Error bars represent the standard error of the 
mean (n = 20 for different sets of true response factors). Asterisks denote when 
MetaboPAC performed significantly better at predicting response factors than both of the 






Figure 23: Percent of response factors predicted by the kinetic equation and 
optimization approaches within each log2 error range for the determined system 
when using noisy data. 
The kinetic equations approach generally predicted more accurate response factors than 
the optimization approach. Error bars represent the standard error of the mean (number of 






Figure 24: Percent of response factors predicted by the kinetic equation and 
optimization approaches within each log2 error range for the underdetermined 
system with regulation when using noisy data. 
The kinetic equations approach generally predicted more accurate response factors than 
the optimization approach. Error bars represent the standard error of the mean (number of 
samples varies based on the percentage of kinetic equations known (Figure 17)). 
 
While there was a predictable decrease in overall performance compared to the 
results when using noiseless data, MetaboPAC was still able to predict 56.3% and 100% 
of response factors within log2(1.5) error for the determined and underdetermined system 
with regulation, respectively, when 100% of the kinetic equations were known. 
Surprisingly, MetaboPAC seems to perform better on the underdetermined system with 
regulation compared to the determined system at 100% known kinetic equations, despite 




determined system (with fewer reaction kinetics and no regulation, and therefore fewer 
instances of response factors within the mass balance equations) may actually hinder 
identification of accurate response factors in this instance. 
For the two biological systems, MetaboPAC was still found to significantly 
predict response factors more accurately than random response factors or response factors 
of 500 for most of the log2 error ranges when 100% of the kinetic equations were known 
under low sampling and high noise conditions (Figure 25 and Figure 26). Once again, 
MetaboPAC showed some improved performance when under conditions where there 
was a high sampling frequency or low noise. Interestingly, the optimization approach 
often performed better than the kinetic equations approach when a low percentage of 
kinetic equations was known (Figure 27 and Figure 28), which was less common in the 
synthetic systems. In some cases, the optimization approach alone (0% known kinetic 
equations) was even significantly better than randomly predicting response factors or 
response factors of 500. This observation illustrates that both the kinetic equations and 
optimization approaches are important to the framework. When a low percentage of 
kinetic equations were known (20% to 60%), the performance of MetaboPAC was 
sometimes worse than its performance when using only the optimization approach. We 
found that these low percentages led to systems of non-linear equations in the kinetic 
equations approach that did not contain a large enough number of equations to reliably 
predict accurate response factors when using noise-added data. Instead, poor response 
factors were predicted by the kinetic equations approach, which led to the optimization 
approach underperforming when predicting the remaining response factors. If only a low 




produce more accurate results. 
 
  
Figure 25: MetaboPAC performance on all conditions of noisy data for the S. 
cerevisiae system. 
MetaboPAC compared to random response factors and response factors of 500 for the S. 
cerevisiae system using error ranges of log2(1.1), log2(1.3), and log2(1.5) on data with 
different sampling frequencies (nT = 50 or 15) and noise added (CoV = 0.05 or 0.15). 
Lines represent the mean percent of predicted response factors within the error ranges for 
each method. Error bars represent the standard error of the mean (n = 20 for different sets 
of true response factors). Asterisks denote when MetaboPAC performed significantly 
better at predicting response factors than both of the other two methods (two-sample t-






Figure 26: MetaboPAC performance on all conditions of noisy data for the E. coli 
system. 
MetaboPAC compared to random response factors and response factors of 500 for the E. 
coli system using error ranges of log2(1.1), log2(1.3), and log2(1.5) on data with different 
sampling frequencies (nT = 50 or 15) and noise added (CoV = 0.05 or 0.15). Lines 
represent the mean percent of predicted response factors within the error ranges for each 
method. Error bars represent the standard error of the mean (n = 20 for different sets of 
true response factors). Asterisks denote when MetaboPAC performed significantly better 
at predicting response factors than both of the other two methods (two-sample t-test with 






Figure 27: Percent of response factors predicted by the kinetic equation and 
optimization approaches within each log2 error range for the S. cerevisiae system 
when using noisy data. 
At low percentages of known kinetic equations, the optimization approach often 
performed better than the kinetic equations approach. At around 80% known kinetic 
equations, the kinetic equations approach began to have improved performance over the 
optimization approach. Error bars represent the standard error of the mean (number of 






Figure 28: Percent of response factors predicted by the kinetic equation and 
optimization approaches within each log2 error range for the E. coli system when 
using noisy data. 
At low percentages of known kinetic equations, the optimization approach often 
performed better than the kinetic equations approach. At around 60% known kinetic 
equations, the kinetic equations approach began to have improved performance over the 
optimization approach. Error bars represent the standard error of the mean (number of 




MetaboPAC has shown substantial potential to provide accurate absolute 
concentrations for metabolites in well-studied metabolic pathways (e.g. central carbon 




systems. Metabolomics research in common microorganisms, such as E. coli and S. 
cerevisiae, could  benefit significantly from MetaboPAC, as it will allow metabolomics 
data to be more seamlessly integrated with metabolic modeling frameworks and data 
analysis methods that require absolute concentrations. The key component of 
MetaboPAC is the use of mass balances within a system with known stoichiometry. 
Previously, mass balances have been used to determine quenching leakage in 
metabolomics121, but to the best of our knowledge, this is the first time mass balances 
have been used in the context of inferring absolute concentrations. Because MetaboPAC 
leverages the mass balances of a system to predict its response factors, it is unsurprising 
that the performance of MetaboPAC is hindered under conditions with high noise, as the 
mass balances can be affected. Nevertheless, MetaboPAC still significantly outperformed 
the other two methods assessed when all kinetic equations are known, suggesting that 
systems with known kinetic structures would benefit from MetaboPAC. 
One of the strengths of MetaboPAC is that additional information can be easily 
integrated into the framework to reduce the number of possible sets of response factors. If 
the minimum or maximum possible or predicted concentrations of each (or a few) 
metabolites are known, this can greatly reduce the search space of possible sets of 
response factors. We found that constraining the range of possible response factors of one 
metabolite would often lead to the range of possible response factors of other metabolites 
also being constrained, especially metabolites nearby in the metabolic pathway. This is 
likely due to their mass balances sharing some of the same reaction fluxes. Along those 
lines, chemical standards could be used for some metabolites, which would decrease the 




to more constrained ranges of possible response factors for some metabolites. 
Along with incorporating additional information directly into the framework, 
MetaboPAC could also be used concurrently with other metabolomics methods to 
improve the accuracy of response factor predictions. The use of methods focused on 
predicting ionization efficiencies114-116 in conjunction with MetaboPAC could provide 
further insight about which response factors predicted by MetaboPAC are most likely to 
be accurate if the inferred concentrations of MetaboPAC and the ionization efficiency-
based platforms are similar. When working with underdetermined systems, methods such 
as dynamic flux estimation122, 123 or flux balance analysis34 could be applied to determine 
more likely flux distributions than the Moore-Penrose pseudoinverse approach used in 
MetaboPAC, which could lead to improved predictions of response factors when using 
the optimization approach. Alternatively, if minimum or maximum values of individual 
fluxes are known, this could also reduce the number of possible flux solutions and benefit 
the calculation of penalties in the optimization approach. 
In this proof-of-principle work, there are two key assumptions we have used to 
initially assess MetaboPAC. These assumptions are reasonable to assume for this work, 
but they will need to be adjusted in the future for MetaboPAC to be more widely 
applicable. First, we assumed the relationship between relative abundances and their 
absolute concentrations is linear. These relationships are not always linear in 
experimental data and non-linear relationships will need to be considered in the future . 
Both the kinetic equations and optimization approaches within MetaboPAC can be easily 
adjusted to account for non-linear relationships, but determining which metabolites have 




information is not known a priori.  
MetaboPAC also assumes the true response factors are sampled from a uniform 
distribution. Under the most realistic conditions, this may not be the case. To further 
assess the robustness of MetaboPAC, we tested the framework on noiseless relative 
abundance data from the two biological systems (assuming all kinetic equations are 
known) where the true response factors were drawn from a log uniform distribution 
(Figure 29). While there is a decrease in performance when using MetaboPAC on both 
biological systems compared to the results in Figure 18, this drop in performance is also 
seen in both the random and 500 response factor methods. MetaboPAC is still 
significantly better than the other two methods by a wide margin in all log2 error ranges 
examined, which indicates that MetaboPAC is still suitable even if response factors are 







Figure 29: MetaboPAC Performance when true response factors are sampled from 
a log uniform distribution. 
To further test the robustness of MetaboPAC, the true response factors were drawn from 
a log uniform distribution instead of a uniform distribution for the two biological systems 
with 100% known kinetic equations and noiseless data. MetaboPAC still outperformed 
the other two methods across all log2 error ranges in both the S. cerevisiae and E. coli 
systems. Bars represent the mean percent of predicted response factors within the error 
ranges for each method. Error bars represent the standard error of the mean (n = 20 for 
different sets of true response factors). 
 
While the results presented here are promising, MetaboPAC currently has some 
limitations. First, because MetaboPAC leverages the stoichiometric mass balance of a 
biological system to identify response factors, it can only be used in the context of 
cellular metabolism in its current form. For example, MetaboPAC could not infer the 
absolute concentrations of metabolites in a blood sample because blood metabolite 
profiles are determined from metabolic contributions from across organs or systems in an 
organism with no stoichiometric basis to connect concentrations124.  
Perhaps the greatest obstacle for MetaboPAC is noisy data. In our results, we 
have determined that MetaboPAC performs particularly well on datasets with little or no 
noise, even when the kinetics of the system are not fully known. Under the noisiest 




better than other methods for predicting response factors when all kinetic equations were 
known, but there is a noticeable decrease in accuracy. Leveraging the mass balances of a 
metabolic system is one of the critical ideas behind MetaboPAC and it is not surprising 
that data with high noise affect these calculations. Here, we have used a Gaussian filter to 
smooth the noisy data, which has proven to be effective, but other venues for mitigating 
the effect of noise should be considered. Exploring other options to reduce noise, such as 
filtering, normalization, scaling, other smoothing methods102, 103, 125, or using triplicate 
samples as is common when collecting metabolomics data, could prove useful and lead to 
an increase in performance. 
 
3.5 Conclusions 
The need for chemical standards in mass spectrometry methods to absolutely 
quantify metabolomics data has been a challenging obstacle that has prevented the direct 
use of metabolomics in many metabolic modeling tools. MetaboPAC is a critical step 
toward preprocessing metabolomics data so that it can be readily used with metabolic 
modeling and other computational platforms that require absolute concentrations of 
metabolites. For well-studied systems, where the entire kinetic structure is known, 
MetaboPAC can infer absolute concentrations with high accuracy. Under conditions 
where the amount of noise in the data is minimal, MetaboPAC can still provide valuable 
information if the kinetic equations are only partially known. As research in 
metabolomics continues to grow and more computational frameworks aim to harness all 
the information that metabolomics data has to offer, MetaboPAC has the potential to 




CHAPTER 4: Improved Kinetics Constraints Increase the Predictivity 






Mathematical and computational models are often used to study metabolism, the 
set of reactions that supply the chemical precursors necessary for almost all cellular 
processes. These metabolic models are significantly cheaper and faster to run than 
laboratory experiments, meaning that they can be of tremendous value when they are able 
to predict how changes in or to a metabolic system can affect its state. While a few 
pathways and sections of metabolism (e.g., glycolysis and central carbon metabolism) 
have been modeled and characterized quite well in a few organisms (e.g., Saccharomyces 
cerevisiae and Escherichia coli)44, 50, genome-scale models that capture metabolism at a 
systems scale have been more difficult to develop. Metabolism involves many 
interconnected reactions and pathways, making it critical to include as much of 
metabolism as possible in metabolic models to better represent the system and generate 
accurate predictions. Metabolomics has great potential to provide the information 
necessary to drive systems-scale metabolic models. However, creating genome-scale 
metabolic models that capture critical system behaviors like metabolic dynamics remains 
an outstanding challenge in the field, which has prevented the value of metabolomics data 
in this context from being fully realized.  
To address this challenge, we recently developed Linear Kinetics-Dynamic Flux 
Balance Analysis (LK-DFBA), a modeling strategy to efficiently track metabolite 




unrolling the temporal aspect of the system into a larger stoichiometric matrix that 
captures metabolite dynamics while retaining a LP structure. The most critical element to 
accomplishing this goal is the addition of linear kinetics constraints that model the 
interactions between metabolites and the reactions whose fluxes they affect, including 
mass action kinetics and allosteric regulatory interactions. The number of parameters in 
LK-DFBA that need to be estimated can be far fewer than in ODE models due to these 
linear kinetics constraints. This enables LK-DFBA to potentially be applied to metabolic 
systems of all sizes, with a smaller increase in computational burden compared to ODE 
models. Furthermore, because LK-DFBA retains a linear structure, it can potentially be 
used with many existing metabolic modeling tools that require constraint-based models, 
such as OptKnock126. We have previously shown that LK-DFBA can outperform ODE-
based modeling approaches when used in conditions most relevant to metabolomics data 
(low sampling frequency and high noise). A framework such as LK-DFBA that can 
model systems at the genome scale is essential to take full advantage of metabolomics 
data. 
In our initial description of LK-DFBA, we explored two different approaches for 
model parameterization. The first approach, LK-DFBA (LR), parameterizes constraints 
solely via linear regression of interacting metabolite concentration and flux data. The 
second approach, LK-DFBA (LR+), uses the parameters from the linear regressions as 
initial seeding values for a secondary optimization to identify the optimal constraints for 
each interaction. While LK-DFBA (LR+) yields better fits to training data than LK-
DFBA (LR), the latter approach estimates its parameters with trivial computational effort 




DFBA (LR) may be the preferable approach for the efficient construction and 
parameterization of metabolic models at the genome scale.  
However, the overall LK-DFBA framework still has some limitations in terms of 
how accurately it represents the underlying biology and biochemistry of the system. For 
example, the linear kinetics constraints used in LK-DFBA (LR) may be viewed as crude 
approximations of the interactions between metabolites and fluxes, which are typically 
non-linear in nature. While kinetic equations found in ODE models (such as Michaelis-
Menten or biochemical system theory (BST) representations97, 127) can capture the non-
linearity of these interactions, the current linear framework in LK-DFBA cannot. 
Additionally, when allosteric regulatory information is considered (which LK-DFBA 
includes in its framework), reaction fluxes are often controlled by multiple metabolites. 
Currently, LK-DFBA creates separate constraints for each metabolite that controls a flux, 
which precludes modeling how multiple metabolites simultaneously interact with a 
reaction flux. 
Since the linear kinetics constraints are so critical to the function of LK-DFBA, it 
is likely that improving those constraints could have a substantial impact on LK-DFBA’s 
ability to capture and predict biological phenomena. Accordingly, we devised three new 
types of kinetics constraints for LK-DFBA to account for biologically relevant features 
like non-linearity and simultaneous regulation by multiple metabolites. These new 
approaches were compared to the original LK-DFBA (LR) constraints by testing on 
synthetic model systems as well as models based on Lactococcus lactis and Escherichia 
coli44, 50 metabolism. We also probed these constraint approaches for their robustness to 




We found that these new constraint approaches can improve model performance, and that 
the optimal constraint approach varied depending on the system being modeled but was 
consistent across perturbations for any given model. We also showed that the LK-DFBA 
approach chosen for the L. lactis and E. coli models can be used to predict changes in 
several critical metabolites and fluxes in agreement with literature experimental results. 
These improvements to LK-DFBA and demonstration of its effectiveness on new 
metabolic models support its attractiveness as a framework for modeling increasingly 
large metabolic systems in the future. 
 
4.2 Linear Kinetics Dynamic Flux Balance Analysis (LK-DFBA) 
 Linear Kinetics-Dynamics Flux Balance Analysis (LK-DFBA) is a recently 
developed modeling strategy that is both scalable and capable of capturing metabolite 
dynamics. The full details of this approach have been described in detail previously56, so 
we only outline the most important aspects of our framework here. In brief, LK-DFBA 
uses an LP-based structure with temporal dynamics modeled by discretizing time and 
unrolling the system into a larger matrix representing each timepoint separately, with an 
objective function that reflects the unrolling of the model. Linear inequality constraints 
that model mass action kinetics and metabolite-dependent regulation are included in the 
model; they are the driving force behind metabolite accumulation and depletion by 
limiting the maximum flux allowed based on the availability of metabolites over time. To 
parameterize these constraints, the LK-DFBA (LR) approach uses linear regression on 
assumed available metabolomics and fluxomics data, as described in the next section. If 




values from concentration data123. In the LK-DFBA (LR+) method, the parameters from 
the LK-DFBA (LR) approach are used as initial conditions in a secondary optimization 
step that finds improved kinetics constraint parameters, though at the cost of 
computational time. Because LK-DFBA retains an LP structure, it is readily scalable and 
has the potential to be used with current constraint-based modeling tools. 
 
4.3 Methods for Improving LK-DFBA 
4.3.1 Constraint approaches 
Throughout this work, we examined the original LK-DFBA (LR) approach and 
three new constraint approaches described in detail below. 
 
4.3.1.1 LK-DFBA (LR)  
The original LK-DFBA approach uses linear kinetics constraints to model the 
interaction between a metabolite and a flux, parameterized using available metabolomics 
and fluxomics data. These constraints take the form of 𝑣 < 𝑎𝑥 + 𝑏, where v is the flux 
being constrained, x is the concentration of a metabolite that interacts with the flux, and a 
and b are the linear constraint parameters. These interactions may be due to mass action 
kinetics, where the interactions are known based on the stoichiometric topology of the 
system, or they may stem from allosteric regulation. While we have previously shown 
that these linear approximations of metabolic interactions can be effective for modeling 
metabolism, they are still approximations of the true non-linear and interconnected 
biochemical relationships in metabolism. Below, we discuss three new constraint 




4.3.1.2 LK-DFBA (NLR) 
While the key advantage of using constraint-based models is their LP structure 
that enables efficient identification of the optimal solution of the problem, most 
metabolite-flux interactions exhibit non-linear behavior that may not be captured well by 
linear equations. Recently, computational solvers have improved such that quadratically 
constrained programs (QCPs) are not much more computationally expensive than LPs. 
Accordingly, we implemented quadratic constraints into the LK-DFBA framework to 
explore their potential for improving model accuracy with only a modest increase in 
computational time. One important aspect of LPs and QCPs is that all of the constraints 
must create a convex feasible solution space in order to guarantee that a global optimum 
can be found52. If 𝑣 < 𝑎𝑥2 + 𝑏𝑥 + 𝑐 represents a quadratic constraint, where v is the flux 
being constrained, x is the concentration of a metabolite that interacts with v, and a, b, 
and c are the parameters of the quadratic constraint, a must be a negative value to retain a 
convex solution space. If a is found to be a positive value during parameterization, we 
convert the quadratic constraint into its original linear form as found in LK-DFBA (LR). 
We refer to this overall approach as LK-DFBA (NLR). 
 
4.3.1.3 LK-DFBA (DR) 
Enzymatic reactions are often controlled by more than a single metabolite that can 
either induce or inhibit enzyme activity, which should ideally be captured in the model 
constraints. To model such regulation of a reaction by multiple metabolites, LK-DFBA 
(LR) creates individual linear constraints for each controller metabolite that are 




effects of multiple metabolites working in conjunction to regulate a flux. We 
implemented a new strategy that uses dimensionality reduction to consolidate information 
content from all controller metabolites for a flux into a single constraint. Dimensionality 
reduction is often used in data analysis, including analysis of metabolomics data, to more 
easily represent and digest datasets with many measured variables. Principal component 
analysis (PCA) is one of the most commonly used dimensionality reduction approaches; 
it linearly transforms the original variables into new, orthogonal composite variables 
called principal components that capture as much variance in the original variable data in 
as few principal components as possible128. Ideally, the first or first few principal 
components capture the majority of the variance in the original dataset, which allows one 
to focus only on those composite variables rather than all of the original variables at once. 
Here, we use PCA to capture the maximal variance of the controller metabolite data in a 
single principal component and use that composite variable as the regressor during linear 
regression with the target flux data. These new constraints are represented as 𝑣 < 𝑎𝑃𝐶1 +
𝑏, where v is the flux being constrained, PC1 is the metabolite concentration data 
projected into the first principal component, and a and b are the constraint parameters. 
We refer to this dimensionality reduction approach as LK-DFBA (DR). 
 
4.3.1.4 LK-DFBA (HP) 
Another approach for modeling interactions with multiple metabolites is to use 
hyperplane constraints. Unlike LK-DFBA (DR), which always builds constraints in two 
dimensions (i.e. the target flux vs. the first principal component), the hyperplane 




a target flux. This approach may avoid loss of information content from metabolite data 
as is possible during dimensionality reduction: as the number of metabolites in an 
interaction increases, the likelihood of the first principal component not capturing the 
majority of variance in the data increases. The hyperplane constraint equation can be 
represented as 𝑣 < ∑ 𝑎𝑖𝑥𝑖
𝑛
𝑖=1 + 𝑏, where v is the flux being constrained, n is the number 
of metabolites that interact with v, xi is the concentration of metabolite i, ai is the 
constraint parameter for metabolite xi, and b is another constraint parameter. We refer to 
the hyperplane approach as LK-DFBA (HP). 
 
4.3.2 Translating constraints to contain training data 
We found that translating the constraints such that all training data fall in the 
region under the inequality constraint decreased the possibility of the computational 
solver encountering infeasible solutions when simulating metabolite dynamics. Thus, for 
all LK-DFBA approaches, each constraint was translated to contain the training data by 
increasing the intercept of the constraint (i.e. the b parameter in LK-DFBA (LR), LK-
DFBA (DR), and LK-DFBA (HP), and the c parameter in LK-DFBA (NLR)) until no 
training data were above each constraint. 
 
4.3.3 Test models 







4.3.3.1 Synthetic model 
The first system we examine is a simple synthetic model with five metabolites 
and five fluxes that was derived from a branched pathway model used previously56. This 
system is based on an ODE-based modeling framework that uses power-law kinetics to 
represent reaction fluxes97. The kinetic equations for each pathway are shown in Figure 
30. To create a variety of synthetic models with the same stoichiometric topology, we 
randomly generated a and b parameters in each kinetic equation. The parameters for each 
model can be found in Table 6. Time course metabolite and flux data were generated by 
solving the ODE system in MATLAB (2018b). 
 
 
Figure 30: Synthetic model.  
Adapted from another branched pathway model used in previous work56. v1, v2, v3, v4, 
and v5 are system fluxes (black arrows) and x1, x2, x3, x4, and xBM are metabolites, where 
xBM is a metabolite representing biomass. Green and red arrows represent positive and 
negative regulatory interactions, respectively. ODE equations for the model are shown in 
the inset, where blue a and b parameters are mass action kinetic parameters and green and 






Table 6: Kinetic parameters in synthetic models.  
Parameters were randomly generated using a uniform distribution between 0.1 and 1.0 (or 
-1.0 to -0.1 for b2r4, which is a parameter that describes inhibition in the system). k 
represents the model number. 
  Kinetics Initial Conditions 
k a2 b21 b2r4 a3 b32 a4 b42 b4r3 a5 b53 b54 X1 X2 X3 X4 XBM 
1 0.8 0.5 -0.2 1.0 0.75 0.5 0.4 0.8 0.5 0.5 0.8 0.1 0.2 0.3 0.4 0.5 
2 0.7 0.5 -0.2 0.8 0.2 0.2 0.9 0.7 0.9 0.4 0.9 0.3 0.3 0.6 0.5 0.2 
3 0.1 0.5 -0.7 0.6 0.9 0.6 0.3 0.9 0.2 0.4 0.3 0.4 0.9 0.6 0.1 0.9 
4 0.9 0.4 -0.2 0.6 0.8 0.4 0.9 0.6 0.5 0.2 0.7 0.8 0.1 0.5 0.7 0.8 
5 0.2 0.4 -0.2 0.9 0.6 0.6 0.3 0.6 0.5 0.7 0.8 0.5 0.5 0.8 0.5 0.2 
6 0.1 0.6 -0.3 0.3 0.9 0.5 0.1 0.7 0.6 0.8 0.6 0.2 0.9 0.2 0.1 0.3 
7 0.5 0.2 -0.2 0.1 0.9 0.2 0.9 0.9 0.6 0.5 0.8 0.2 0.3 0.1 0.7 0.6 
8 0.9 0.4 -0.3 0.8 0.1 0.2 0.9 0.7 0.2 0.6 0.8 0.6 0.4 0.1 0.4 0.4 
9 0.6 0.5 -0.9 0.4 0.6 0.8 0.8 0.4 0.7 0.8 0.9 0.3 0.4 0.2 0.7 0.8 
10 0.6 0.3 -0.9 0.3 0.2 0.6 0.6 0.7 0.6 0.8 0.9 0.4 0.2 0.8 0.1 0.7 
11 0.8 0.2 -0.6 0.7 0.4 0.3 0.7 0.8 0.4 0.1 0.2 0.5 0.1 0.4 0.8 0.4 
12 0.9 0.9 -0.1 0.1 0.4 0.7 0.3 0.3 0.8 0.1 0.8 0.1 0.9 0.9 0.6 0.1 
13 0.2 0.9 -0.8 0.3 0.7 0.6 0.5 0.8 0.6 0.5 0.3 0.3 0.1 0.2 0.4 0.9 
14 0.9 0.5 -0.9 0.1 0.8 0.2 0.7 0.3 0.5 0.8 0.5 0.9 0.7 0.3 0.5 0.9 
15 0.6 0.8 -0.7 0.1 0.2 0.2 0.9 0.9 0.9 0.9 0.2 0.2 0.8 0.2 0.4 0.5 
16 0.1 0.2 -0.7 0.8 0.5 0.5 0.9 0.4 0.3 0.2 0.6 0.8 0.8 0.2 0.1 0.5 
17 0.3 0.4 -0.3 0.7 0.5 0.9 0.5 0.2 0.7 0.6 0.3 0.5 0.1 0.8 0.3 0.2 
18 0.5 0.9 -0.4 0.3 0.6 0.4 0.2 0.3 0.7 0.5 0.6 0.9 0.4 0.6 0.2 0.9 
19 0.9 0.8 -0.6 0.9 0.7 0.6 0.2 0.6 0.4 0.1 0.7 0.1 0.3 0.5 0.2 0.2 
20 0.9 0.9 -0.2 0.1 0.7 0.3 0.3 0.5 0.6 0.4 0.7 0.4 0.8 0.2 0.3 0.4 
 
4.3.3.2 Lactococcus lactis model  
This model was created by Costa et al. and comprises central metabolism and 
production pathways for important metabolites such as mannitol and 2,3-butanediol 50. 
The L. lactis model consists of 26 metabolites and 21 fluxes and is publicly available on 
KiMoSys129. Noiseless data were generated in COPASI 4.24 (Build 197) using the 
default initial conditions and parameters over a simulation time of two hours. 
 
4.3.3.3 Escherichia coli model  
The E. coli model developed by Chassagnole et al. encompasses glycolysis and 
the pentose phosphate pathway44. This model is publicly available on KiMoSys but was 




coli model’s topology and stoichiometry. Noiseless data for the original E. coli model 
were generated in MATLAB (2018b) using the default initial conditions and parameters, 
while random initial conditions and parameters were used for the new models with the E. 
coli topology. To be consistent with our previous work, we used a simulation time of ten 
seconds56. 
 
4.3.4 Kinetic parameters in E. coli models 
Parameters were randomly generated by drawing from the random normal 
distribution 𝑁𝑖 ~ (p𝑖,p𝑖) and taking the absolute value, where pi is the original value of the 
ith parameter. Some parameters, such as the feed rate, dilution rate, and rates of synthesis 
reactions were kept at their original parameter values to ensure the models were viable. 
 
4.3.5 LK-DFBA objective functions 
Like other constraint-based methods, LK-DFBA requires an objective function, 
which is usually tied to some presumed goal of the system (such as maximizing biomass 
or ATP production). FBA models for specific organisms commonly have a separate flux 
reaction dedicated to biomass, made up of precise ratios of different metabolites. While 
LK-DFBA models with tuned objective functions can be created, the biological models 
we sought to use here do not have pre-existing tuned objective functions, so we instead 
focused on LK-DFBA’s performance using generic objective functions.  
Here, we have chosen flux v5 as the objective function for the synthetic model, as 
it is the only efflux out of the system. For the L. lactis model, we use the LDH pathway 




in the organism (which is commonly used for dairy products) and was the metabolite 
produced at the highest levels in the original L. lactis model50. The objective function 
used for the E. coli model was to maximize all effluxes from the system, which included 
murein synthesis, glycerol-3-phosphate dehydrogenase, serine synthesis, PEP 
carboxylase, DAHP synthesis, pyruvate dehydrogenase, ribose phosphate 
pyrophosphokinase, glucose-1-phosphate adenyltransferase, the synthesis of murein and 
chorismate from PEP, and the synthesis of isoleucine, alanine, α-ketoisovalerate, and 
diaminopimelate from pyruvate. While we have observed that these objective functions 
can be further improved, and approaches have been developed for finding an optimal 
objective function for a model by creating a bilevel optimization problem and then 
leveraging the duality theorem130, 131, our chosen objective functions were sufficient to at 
least qualitatively model the synthetic, L. lactis, and E. coli systems. 
 
4.3.6 Pathway perturbations 
 To test the ability of LK-DFBA to predict metabolic behaviors not represented in 
the training data, we introduced perturbations into each system either through down-
regulation (indicated with a prefix ‘d’ in all figures) or up-regulation (indicated with a 
prefix ‘u’) of reaction fluxes. For the synthetic models, we down-regulated v2, v3, and v4 
by multiplying their constraint equation parameters (which restricts their maximum 
allowable flux value) by 0.5x and up-regulated these pathways by doubling the constraint 
equation parameters. The pathways and reactions to be perturbed in the L. lactis 50, 132-135 
and E. coli45, 136-139 models were chosen based on previous literature. Reactions in the L. 




phosphatase) were down-regulated to 0.1x their original parameter values (since 
completely knocking out reactions would often produce infeasible solutions for the linear 
program) and up-regulated to 2x their original parameter values, magnitudes that were 
necessary to effect significant perturbations to the system’s behavior. Reactions in the E. 
coli model (pyruvate kinase, phosphoglucose isomerase, glyceraldehyde-3-phosphate 
dehydrogenase, phosphofructokinase, triose-phosphate isomerase, ribulose-phosphate 
epimerase, phosphoglucomutase) were down-regulated to 0.1x and up-regulated to 2x 
their original parameter values. 
 
4.3.7 Generating noisy data 
 Noise was introduced into the system by down-sampling the original noiseless 
data (originally 50 timepoints) into nT timepoints that are evenly spaced over the time 
interval of interest. Both metabolite and flux values were then replaced with a random 
value drawn from 𝑁𝑖,𝑘 ~ (𝑦𝑖(𝑡𝑘),𝐶𝑜𝑉∙𝑦𝑖(𝑡𝑘)), where 𝑦𝑖(𝑡𝑘) is the value of species 
(metabolite or flux) 𝑖 at timepoint 𝑘, and CoV is a coefficient of variance. For each 
sampling frequency and CoV condition, ten noisy datasets were generated.  
 
4.3.8 Error calculation 
 The error of the predictions made by LK-DFBA was calculated using a 
normalized root mean squared error (NRMSE) between the LK-DFBA predicted 
metabolite concentrations and the noiseless ODE concentration or experimental data. Pik 
and Rik are the predicted (e.g. results from LK-DFBA) and reference (e.g. ODE model or 




of the concentrations of reference metabolite i across all timepoints to normalize the data 
and N is the total number of data points used in the NRMSE calculation.  
 








 (Equation 7) 
 
4.3.9 Pearson correlation calculation 
 The available E. coli knockout experimental data consisted of steady-state flux 
data, so to compare these to the knockout predictions made by LK-DFBA (which did not 
yield a steady state over the ten second time interval of the model) we used the average 
flux of our time course predictions. Because the average flux of our predictions and the 
steady-state fluxes of the experimental data are different measurements and therefore not 
directly comparable using NRMSE, we chose to use a Pearson correlation coefficient to 
evaluate our framework, which was recently used in a similar comparative analysis of 
metabolic models140. High correlations between steady-state flux experimental data and 
the average flux predictions would indicate that LK-DFBA can effectively predict if gene 
knockouts lead to an increase or decrease in flux for modeled reactions. The calculation 
for the Pearson correlation coefficient is shown in Equation 8, where Ai is the average of 
the predicted flux profile for the ith flux, vi is the flux value of the ith flux from the 
experimental data, ?̅? is the mean across all fluxes for the average of computationally 
predicted fluxes,  ?̅? is the mean flux value across all fluxes for the experimental data, and 
n is double the number of fluxes that are shared between both the E. coli model and 















   (Equation 8) 
 
4.4 Results 
4.4.1 Fitting and predicting phenotypes in synthetic models 
 We generated twenty random sets of parameters and initial conditions for the 
kinetic equations in the synthetic model to examine if different constraint approaches 
were more suitable for different models. We produced in silico metabolite concentration 
and flux data over a time interval of ten seconds by solving the ODEs in each synthetic 
system. The four constraint approaches were used for parameterization of LK-DFBA 
models to the twenty datasets. The fitted LK-DFBA models were then simulated over the 
same ten second interval using the initial conditions for each respective synthetic system 
to compare against the original ODE data. This process was performed on both noiseless 
(nT = 50, CoV = 0) and noise-added data with different sampling frequencies (nT = 50 or 
15) and levels of noise (CoV = 0.05 or 0.15). To test the ability of each LK-DFBA 
approach to predict the effects of defined genetic perturbations, we down- and up-
regulated the v2, v3, and v4 pathways in the original kinetic equations by multiplying the 
kinetic coefficient parameters (a parameters in the inset of Figure 30) by 0.5x or 2x, 
respectively, and generating new ODE data. We then simulated the LK-DFBA model 
after adjusting the fitted LK-DFBA constraints to reflect the down- or up-regulation by 
multiplying the kinetics constraint parameters by 0.5x and 2x, respectively. The NRMSE 




data from the perturbed synthetic models was then calculated. 
 For the noiseless cases with no genetic perturbation (WT) as shown in the first 
row below each bold line in Figure 31, the best-fitting constraint approach (dark green) 
varied across the different models. All four approaches performed best for at least one of 
the models. When fluxes were either down- or up-regulated via in silico genetic 
perturbations and LK-DFBA models fitted to the WT ODE data were used to predict 
these changes, the best constraint approach across all perturbations (dV2 through uV4) 
was generally consistent with the best approach in the absence of perturbations. 
 When using noisy data, similar trends were observed (representative example in 
Figure 32). While the best constraint approach for WT noisy data was not always the 
same as the best approach for noiseless data, the best constraint approach for a given 
noisy WT dataset was still generally the best for predicting the impacts of in silico 
genetic perturbations in the same model (dV2 through uV4). Interestingly, noisy data 
negatively affected the performance of LK-DFBA (HP) to a much greater extent than the 
other approaches, which caused LK-DFBA (HP) to never be identified as the best 
approach in the condition with the lowest sampling frequency and highest noise (nT = 15, 
CoV = 0.15). Similar results were found under other noisy conditions (Figure 50 through 






Figure 31: NRMSE heatmap of LK-DFBA approaches on different synthetic models 
using noiseless data.  
Each constraint approach was used to fit parameters to wild-type (WT) noiseless data (50 
timepoints) and then used to simulate the WT system and in silico genetic perturbations 
with fluxes v2, v3, or v4 down- or up-regulated. Dark green boxes represent the lowest 
NRMSE within each perturbation for each synthetic model, while dark red boxes 
represent the highest NRMSE (meaning that the dynamic range of the color scale varies 
for each perturbation for each synthetic model to better convey the relative performance 
of different methods). The cells with bolded white numbers indicate the LK-DFBA 
approach that best fits the WT data. Cells with white numbers are generally consistently 
green, indicating that fitting to WT data is a good indicator of which approach will be 







Figure 32: NRMSE heatmap of LK-DFBA approaches on different synthetic models 
using noise-added data (nT = 15, CoV = 0.15).  
Each constraint approach was used to fit parameters to noisy (nT = 15, CoV = 0.15) wild-
type (WT) data and then used to simulate the WT system and the system with in silico 
genetic perturbations with fluxes v2, v3, or v4 down- or up-regulated. Dark green boxes 
represent the lowest average NRMSE (N = 10) within each phenotype for each synthetic 
model, while dark red boxes represent the highest average NRMSE. The cells with 
bolded white numbers indicate the LK-DFBA approach that best fits the WT data. 
 
 
We also tested the effect of smoothing the noisy (nT =  15, CoV = 0.15) 
metabolite concentration and flux time course profiles by fitting to a previously 




lower error of the final model but requires increased computation time for estimating the 
parameters of the impulse function and in certain cases can actually increase error if a 
specific dataset deviates significantly from all of the profiles that an impulse function can 
capture. The best constraint approach for WT smoothed data was the same as for 
unsmoothed data in 19 of the 20 models. As with the unsmoothed cases, the best 
constraint approach for smoothed data was typically consistent between WT and in silico 
genetic perturbations, and there were no cases where LK-DFBA (HP) performed the best 






Figure 33: LK-DFBA performance on noisy synthetic model data after smoothing.  
Each constraint approach was used to fit parameters to noisy (nT = 15, CoV = 0.15) wild-
type (WT) data that was smoothed with a previously described impulse function100, and 
then used to simulate the WT system and the system with in silico genetic perturbations 
with fluxes v2, v3, or v4 down- or up-regulated. Dark green boxes represent the lowest 
average NRMSE (N = 10) within each phenotype for each synthetic model, while dark 
red boxes represent the highest average NRMSE. The cells with bolded white numbers 
indicate the LK-DFBA approach that best fits the WT data. 
 
4.4.2 Fitting and predicting phenotypes in L. lactis and E. coli models 
 For the L. lactis model, we tested the four constraint approaches on noiseless data 
and noisy data under different conditions (nT = 50 or 15, CoV = 0.05 or 0.15). On the 




which also had the lowest NRMSE when predicting the results of perturbations to five 
different pathways (Figure 34). At high sampling frequencies and low noise (nT = 50, 
CoV = 0.05), LK-DFBA (HP) still performed the best, but as more noise was added or 
lower sampling frequencies were used, LK-DFBA (NLR) was optimal. This is consistent 
with the findings described above for the small synthetic systems where LK-DFBA (HP) 
can produce low NRMSE with noiseless data but has difficulties under more realistic 
conditions. 
 As with the L. lactis model, we tested all constraint approaches on both noiseless 
and noisy data from the E. coli model under different conditions (nT = 50 or 15, CoV = 
0.05 or 0.15). For this model, LK-DFBA (NLR) was the best constraint approach for 
noiseless data (Figure 35). Noisy E. coli data produced the same results: for all noisy 
conditions, LK-DFBA (NLR) was optimal for the WT system. It was also optimal for 
almost all of the in silico genetic perturbations, showing once again that the same 
constraint approach that was optimal for the WT system at a given sampling condition 






Figure 34: NRMSE heatmaps of constraint approaches on model of L. lactis 
metabolism.  
Each constraint approach was used to fit parameters to wild-type (WT) L. lactis data and 
then used to simulate the WT system and the system with in silico genetic perturbations 
with literature-reported important pathways down- or up-regulated. Dark green boxes 
represent the lowest NRMSE within each phenotype for each model, while dark red 
boxes represent the highest NRMSE. Heatmaps show the mean of 10 noisy datasets, 






Figure 35: NRMSE heatmaps of constraint approaches on model of E. coli 
metabolism.  
Each constraint approach was used to fit parameters to wild-type (WT) E. coli data and 
then used to simulate the WT system and the system with in silico genetic perturbations 
with literature-reported important pathways down- or up-regulated. Dark green boxes 
represent the lowest NRMSE within each phenotype for each model, while dark red 
boxes represent the highest NRMSE. Heatmaps show the mean of 10 noisy datasets, 




We also perturbed the original parameters and initial conditions (drawing from 
the random normal distribution 𝑁𝑖 ~ (p𝑖,p𝑖) and taking the absolute value, where pi is the 
original value of the ith parameter) of the E. coli model to create five new models with 
the same topology. As with the twenty different versions of the small synthetic system, 
we found that the best constraint approach was not conserved across models with the 
same topology as the original E. coli model when tested on noiseless data (Figure 36). 
Instead, the rates of individual reactions and how they affect overall model dynamics 





Figure 36: LK-DFBA performance on different models with the same stoichiometric 
topology as the E. coli model.  
Five models with the same topology as the original E. coli model were created by 
randomizing the original kinetic parameters. The four LK-DFBA approaches were 
evaluated on noiseless data generated by these new models. Dark green boxes represent 
the lowest NRMSE within each phenotype for each model, while dark red boxes 
represent the highest NRMSE. The cells with bolded white numbers indicate the LK-
DFBA approach that best fits the WT data. Cells with white numbers are generally 
consistently green, indicating that fitting to WT data is a good indicator of which 




4.4.3 Improved LK-DFBA predictions yield qualitative consistency with experimental 
L. lactis metabolite concentration data 
 To further assess how well LK-DFBA performs when predicting different 
phenotypes, we compared the predictions of LK-DFBA to available experimental data for 
the first time. The previously described ODE-based L. lactis model was originally 
parameterized using experimental metabolite time course data from L. lactis cultures 
grown with an initial glucose concentration of 40 mM50 and validated by comparison to 
experimental data from cultures grown at initial concentrations of 20mM and 80 mM 
glucose. Here, we similarly fitted all LK-DFBA approaches to data generated by the 
ODE model at 40 mM glucose and then simulated the LK-DFBA model using the best 
constraint approach at 20 mM and 80 mM initial concentrations of glucose for validation. 
 Figure 37 depicts the metabolite concentrations predicted by LK-DFBA (HP) (the 
best approach for noiseless data in the L. lactis model) for the three initial concentrations 
of glucose when trained on noiseless data. For multiple initial glucose concentrations, 
LK-DFBA (HP) captured the general qualitative trends of glucose (depletion) and lactate 
(accumulation), two key metabolites in L. lactis that are often studied141, 142. For cofactor 
metabolites that participate in many different reactions, such as ATP, NAD(H), and 
inorganic phosphate, it was more challenging for LK-DFBA (HP) to predict their 
concentration profiles over the simulation interval, which is a problem found in other 
modeling frameworks52. Although LK-DFBA’s predictions were overall not as smooth or 
quantitatively accurate as the ODE model, this is to be expected due to the lack of a 
validated objective function for this constraint-based model; the objective function we 




known that the objective function can significantly affect the predictions of FBA 
approaches. Nevertheless, as presented here, LK-DFBA can still qualitatively track 
important metabolite dynamics even when using a crude objective function. This is 
important to note, as many organisms that are not well-studied have no readily available 
objective function to use.  
 
 
Figure 37: Comparison of LK-DFBA metabolite concentration predictions when 
fitted to noiseless ODE data against noiseless ODE data and all available L. lactis 
experimental data.  
Panels A, B, and C depict concentration profiles for LK-DFBA (HP) and the ODE model 
compared to experimental data for initial glucose concentrations of 20 mM, 40 mM, and 
80 mM, respectively. Cofactor concentrations were more challenging to predict, 
exhibiting many spikes upwards or downwards in concentration. Cofactors were involved 
in several kinetics constraints and the spikes in concentrations were likely due to changes 
in which constraints were currently active in the linear program. Nonetheless, the 





 Figure 38 depicts the concentration profiles predicted by LK-DFBA (NLR) (the 
best approach for noisy data in the L. lactis model) after being fitted to 10 noisy datasets 
generated by the ODE model and simulated at 20 mM, 40 mM, and 80 mM initial 
glucose, respectively. Again, the LK-DFBA framework generally captured the qualitative 
trends of major metabolites such as glucose and lactate, though unsurprisingly not as 
accurately as when noiseless data are used and with difficulties predicting cofactor 
concentrations. Because LK-DFBA (NLR) contains quadratic constraints, its results are 
generally smoother compared to the other LK-DFBA approaches, which helped it predict 
some metabolites, such as PEP, arguably better than in the noiseless case. Furthermore, 
LK-DFBA (NLR) is less susceptible to noise for some metabolites, such as glucose and 
lactate, as observed in predicting similar time courses across the 10 noisy datasets. This 
could be advantageous if one is modeling a system with multiple noisy data sets and 
requires consistent predictions for certain metabolites. Likewise, if only using a single 
dataset, LK-DFBA (NLR) can ensure that these metabolic profiles would not 
dramatically change if a different dataset had been used. Other methods, such as the 
original LK-DFBA (LR) approach, can result in more varied predictions (Figure 39) 
depending on the noisy dataset used; some appear to produce better predictions than LK-
DFBA (NLR), while others are worse (though all predictions follow the same trends). 
These observations reiterate that the best approach is dependent on the systems and 
datasets being studied, so having multiple LK-DFBA approaches available is an 





Figure 38: Comparison of LK-DFBA metabolite concentration predictions when 
fitted to noisy data against ODE and all available L. lactis experimental data.  
A., B., and C. present concentration profiles for LK-DFBA (NLR) on 10 noisy datasets 
(nT = 15, CoV = 0.15) and the ODE model compared to experimental data for initial 
glucose concentrations of 20 mM, 40 mM, and 80 mM, respectively. The mean 
concentration profile (solid green line) is shown with each of the concentration profiles 






Figure 39: Comparison of LK-DFBA (LR) metabolite concentration predictions 
against ODE data and L. lactis experimental data when fitted to noisy ODE data. 
Panels A, B, and C depict concentration profiles for LK-DFBA (LR) on 10 noisy datasets 
(nT = 15, CoV = 0.15) and the ODE model compared to experimental data. The mean 
concentration profile (solid green line) is shown with each of the concentration profiles 
(solid red lines) from the 10 noisy datasets. While LK-DFBA (LR) is able to capture the 
general trends of glucose depletion and lactate accumulation, the best LK-DFBA 
approach on noisy data, LK-DFBA (NLR), showed much more consistency in its 
predictions across noisy datasets for glucose and lactate (Figure 38). 
 
4.4.4 Changes in LK-DFBA flux profiles due to gene knockouts are correlated with 
experimental E. coli steady-state flux data 
 We also compared the predictions of the best LK-DFBA approach on the E. coli 
model to experimental steady-state flux data obtained through gene knockout 
experiments by Ishii et al.137. Because the Chassagnole model, which LK-DFBA is fitted 




14 fluxes that are included in both the Chassagnole model and the Ishii steady-state flux 
results. We used the dilution rate of 0.2 h-1 for all experimental data. To emulate a gene 
knockout in the LK-DFBA model, we down-regulated the pathway(s) that correspond 
with the gene by multiplying the parameters of the relevant constraints by 0.1x instead of 
completely removing the reaction, as we found that this sufficiently reduced the possible 
flux reaction rate without causing infeasible solutions from the solver. Additionally, it is 
not uncommon for enzymatic activity to remain in a pathway after single gene knockouts 
due to paralogous enzymes and enzyme promiscuity. Because the LK-DFBA predictions 
do not reach steady-state for the simulation time examined in this work and our previous 
work (ten seconds), we instead used the average flux of the predicted time course to 
describe how LK-DFBA’s predictions change from the wildtype to gene knockout 
phenotype. The average flux before and after a gene knockout should reflect whether the 
reaction rate generally increases or decreases across the studied time interval after a 
system perturbation. We used a Pearson correlation coefficient to determine if the 
average flux profiles predicted by LK-DFBA changed similarly to the experimental data 
after a gene knockout. This assessment method has been used previously by Lima et al. to 
compare multiple E. coli models, including the Chassagnole model, to the Ishii dataset140. 
 To evaluate how our framework compares to E. coli experimental data, we 
examined LK-DFBA (NLR), as it was the best approach in the case of low sampling 
frequency and high noise (Figure 35). Figure 40 shows the average Pearson correlation of 
the LK-DFBA (NLR) flux predictions (after being fitted to ten noisy datasets with nT = 
15 and CoV = 0.15) and the average correlation of the ODE model flux predictions with 




DFBA (NLR) generally gave reliable predictions for whether fluxes increased or 
decreased due to gene knockouts, with correlation values greater than 0.6 in all but two 
cases and correlations greater than 0.7 in 6 out of 13 cases. These correlations were very 
similar to the correlations yielded by the ODE-based model. In 10 out of 13 knockouts, 
the correlations calculated for LK-DFBA outperformed or were within 5% of the 
correlations calculated with the ODE-based model. These results support the significant 
promise of LK-DFBA approaches for predictivity comparable to that of standard models 
but with the additional benefits (including relative model simplicity and potential 
scalability) that accrue from using a LP-based formulation.  
 
 
Figure 40: Pearson correlation coefficients of LK-DFBA and ODE model flux 
predictions with E. coli experimental data.  
LK-DFBA (NLR) was the best approach when fitting on low sampling frequency (nT = 
15) and high noise (CoV = 0.15) data. Blue and red bars represent LK-DFBA (NLR) and 
ODE model mean correlations, respectively, between the average predicted flux profiles 
and experimental steady-state flux data for various gene knockout conditions. Gene 
knockouts in the LK-DFBA and ODE-based models were simulated by down-regulating 







At the outset of this work, we sought to find a single LK-DFBA constraint 
approach that would improve upon the originally published framework. Instead, we have 
shown that the best constraint approach is highly dependent on the system being 
modeled. Despite each of the 20 small synthetic models having the exact same 
stoichiometry and allosteric regulatory interactions, the optimal LK-DFBA approach 
varied for both noiseless and noisy training datasets, with one of the new constraint 
approaches performing the best in the majority of cases. This finding suggests that the 
topology of the system is less important than the emergent dynamics from the collective 
metabolic reactions. It also supports the importance of having multiple types of 
constraints to choose from, as presented in this work, to allow more accurate modeling of 
any given system.  
These conclusions are reinforced by analysis of biological systems, where LK-
DFBA (HP) performs the best on L. lactis noiseless data and LK-DFBA (NLR) performs 
the best on E. coli noiseless data (though LK-DFBA (NLR) is superior for both systems 
when using low sampling frequency and high noise data). We further confirmed that 
topology is not the determining factor by randomizing parameters in the E. coli model 
(Figure 36): again, the best constraint approach varied across these topologically identical 
new models. Many metabolic pathways are conserved topologically across many species 
(e.g. glycolysis), though the kinetic parameters within these pathways can be vastly 
different. This suggests that having multiple LK-DFBA constraint approaches to choose 
from will improve our ability to model different systems. 




parameterizations and topologies, the best approach (in terms of predicting metabolic 
phenotypes) for a given model was generally consistent across a wide range of pathway 
perturbations. This trend remained true whether using noiseless data, data with low 
sampling frequency and high noise, or noisy data that had been smoothed. These results 
instill confidence that the best constraint approach found when fitting to a wildtype 
metabolic system will also be the best approach when predicting changes to that system, 
meaning that an approach that can select the best-fitting of multiple constraint 
frameworks is viable and likely to be successful. One possible reason for the success of 
this approach is that when pathways are down- or up-regulated, it is common for only the 
nearest neighboring pathways to be significantly affected if the change to the system is 
not drastic or the perturbed pathway is not essential for cell survival, meaning that the 
emergent behavior from the system would not change too greatly and thus the same 
constraint approach would be optimal. To easily construct the optimal LK-DFBA model 
for a given biological system, we envision the workflow presented in Figure 41. After 
compiling the relevant system stoichiometry, regulatory information, and metabolomics 
and fluxomics data, one can fit each of the four LK-DFBA approaches to the data and 







Figure 41: Workflow for selecting the best constraint approach for LK-DFBA when 
modeling metabolic systems.  
Dynamic Flux Estimation (DFE) is applied to the system stoichiometry and available 
metabolomics data to infer instantaneous fluxes. The system stoichiometry, 
metabolomics data, inferred flux data, and system regulatory information are then used to 
estimate parameters for each LK-DFBA approach (blue arrow). Using multiple constraint 
approaches (green arrows), four different LK-DFBA models are created and tested for 
their respective abilities to recapitulate training data. The model with the lowest error is 
selected and can be used for future in silico predictions (red arrow). 
 
 Using ODE models and experimental data from L. lactis and E. coli, we found 
that LK-DFBA can effectively predict qualitative trends in concentration profiles of some 
important metabolites. While we have previously shown that LK-DFBA captures 
metabolite dynamics in synthetic data generated by ODE models, this is the first time 
LK-DFBA predictions have been validated with experimental data. For key metabolites 
that are important inputs or outputs of the system (e.g. carbon sources or end products), 
LK-DFBA can qualitatively predict if their concentration profiles are expected to 




engineer organisms to efficiently produce certain metabolites. Cofactors, on the other 
hand, are more difficult to model using LK-DFBA but are still typically predicted to be 
within an order of magnitude of the experimental data in most cases. This capability 
could be useful when assessing levels of accumulating toxic metabolites or cofactor 
imbalances if exact concentrations are not necessary. For LK-DFBA to accurately predict 
the metabolic profiles of cofactors, additional modifications to the framework may be 
necessary to account for metabolites that are involved in multiple reactions and are 
constantly consumed and produced. 
We also found that LK-DFBA flux profile predictions were highly correlated with 
experimental flux data from genetic knockout experiments. Furthermore, these 
correlations were comparable to those found when using the ODE-based model. We note, 
though, that this comparable predictivity is limited by the fact that LK-DFBA was trained 
using ODE-generated data; if it had instead been fitted to actual metabolomics and 
fluxomics time course data used in the Ishii experiments (which is not available), these 
correlation values could possibly be even higher. Similarly, an improved objective 
function over the reasonable but arbitrary and unoptimized one used here could also lead 
to significant improvements in the performance of LK-DFBA. 
By showing for the first time that LK-DFBA can predict changes in metabolite 
concentrations and flux profiles qualitatively, we have demonstrated LK-DFBA’s 
potential as a widely-applicable metabolic modeling tool. Unlike many ODE-based 
modeling approaches that require specific kinetic equations for each flux reaction, LK-
DFBA is generalizable. With four types of kinetics constraints that account for different 




LK-DFBA to be amenable to many different systems. Additionally, applying the four 
LK-DFBA approaches to these models of L. lactis and E. coli has established that our 
framework can handle various biological systems of substantial size without the need for 
computationally taxing parameter estimation steps. Because each of the four LK-DFBA 
approaches maintains an easily solvable LP or QCP structure, LK-DFBA is a prime 
candidate for being one of the first frameworks able to model a variety of genome-scale 
systems while also capturing their metabolite dynamics.  
While the addition of new constraint approaches has significantly improved the 
original LK-DFBA (LR) framework, there are still several areas where LK-DFBA can be 
improved. If computational resources when building the model are not a concern, a 
secondary optimization step can be used, as in the LK-DFBA (LR+) approach, to 
improve the parameters in each of the new constraint approaches. In addition, as 
previously noted the objective function used in LK-DFBA is also a ripe target for future 
efforts to improve this modeling framework. Here we have chosen objective functions 
that lead to the maximization of putatively important fluxes, but unlike many other 
constraint-based models, there was no specific biomass or other objective flux to use. 
Optimizing the weight of each flux or metabolite in the objective function could lead to 
even lower observed errors compared to experimental data and may also provide insight 
into what real biological systems tend to maximize. 
 
4.6 Conclusions 
In this work, we have shown that the LK-DFBA modeling framework can be 




relevance. We showed that there is no single best LK-DFBA constraint approach for all 
models, and the optimal approach depends not just on the topology of the biochemical 
system but also its kinetics and parameters. The constraint approach that performs the 
best in recapitulating training data consistently outperforms other constraint approaches 
at predicting the results of metabolic perturbations on the same system. With these new 
constraint approaches, we are able to model a variety of metabolic systems more 
accurately than if we were to just use the original LK-DFBA (LR) method. Moreover, 
based on comparisons to experimental data we showed that the improved LK-DFBA 
approaches can reasonably capture the qualitative dynamics of important metabolites and 
fluxes of interest to researchers. While these predictions may not be smooth or 
quantitative, the qualitative prediction of trends of metabolite dynamics in response to 
major perturbations is arguably the most critical aspect needed for creating metabolic 
models that give insight on how pathways can be further optimized or how metabolic 
resources can be rerouted to produce valuable chemicals: knowing that a specific 
knockout will increase or decrease flux is often sufficient to justify the expense of 
experimental implementation of such genetic perturbations. Moreover, we expect this 
computational framework to (with future effort) provide opportunities for 
computationally reasonable scale-up to the genome scale. While the acquisition of quality 
metabolomics and fluxomics data to build the constraints in LK-DFBA is still a 
challenge, the work we have presented here lays the groundwork needed to take full 






CHAPTER 5: A Workflow Toward Modeling Dynamics in Metabolic 





The three computational frameworks presented in the previous chapters were all 
built toward the goal of creating a comprehensive workflow for modeling metabolic 
systems, starting from the preprocessing of metabolomics data and ending with the 
construction of the model itself. While each framework was independently developed and 
may not be fully optimized to operate in unison yet, it is important to examine how the 
three platforms perform together in their current states. Not only will this further test the 
robustness of each framework, but it will also provide insight about possible areas of 
improvement that could lead to a more streamlined metabolic modeling workflow. In this 
section, I use a determined system with unknown regulation as a test case for combining 
SCOUR, MetaboPAC, and LK-DFBA to construct a metabolic model. This metabolic 
modeling workflow begins with relative abundance data that is used with SCOUR to 
predict the regulatory structure within the system. Next, this regulatory information is 
provided to MetaboPAC and the absolute concentrations are inferred from the relative 
abundances. Finally, LK-DFBA can construct a dynamic metabolic model with allosteric 
regulation using the regulatory information and absolute concentrations determined in the 






Figure 42: Workflow toward modeling dynamics in metabolic systems.  
In the first step of the workflow, SCOUR identifies the regulatory structure of the system 
using relative abundance metabolomics data. Next, MetabocPAC uses the identified 
regulatory information to infer absolute concentrations. Finally, the identified regulatory 
structure and inferred absolute concentrations are used with LK-DFBA to construct a 
metabolic model. 
 
5.2 Determined system with regulation 
To assess LK-DFBA, SCOUR, and MetaboPAC together, we created a 
determined system containing four metabolites, fives fluxes, and two regulatory 
interactions that were initially unknown (Figure 43). Flux v1 was assumed to be a 
constant known value. The reactions in the system were constructed using Michaelis-
Menten kinetics and different initial conditions were used with the model to generate 15 
datasets of metabolite concentration and flux time courses. Relative abundance data were 
simulated by randomly sampling 20 sets of response factors that were applied to each of 
the 15 ODE datasets for a total of 300 datasets that were used in both the SCOUR and 
MetaboPAC steps. For the LK-DFBA step of the process, only 20 datasets (simulated 
from different response factors but the same initial metabolite concentrations) were used 




ODE data (i.e. the ODE dataset containing the true absolute concentration values and 
same initial metabolite concentrations). 
 
Figure 43: Determined system with regulation used to evaluate the metabolic 
modeling workflow. 
 
5.3 Metabolic modeling workflow 
5.3.1 Method for imputing missing metabolomics data 
Before discussing the performance of all three frameworks together, I would be 
remiss if I did not mention a method for imputing missing values in raw metabolomics 
data that I developed during my thesis. In metabolomics data, it is common for some 
values to be missing due to random analytical instrument error (these values are 
described as missing completely at random (MCAR)) or because the abundance of a 
metabolite is below the limit of detection (these values are described as missing not at 
random (MNAR)). Because missing values in metabolomics data can bias downstream 
analyses or prevent the use of many analysis methods143, researchers typically impute 
these missing values using several common methods, which include replacing missing 
values with zeros, the mean or median of all abundances, or using algorithms such as 




approaches do not consider the difference between values that are MCAR and values that 
are MNAR, which can cause some missing values to be imputed inaccurately. To address 
this issue, we developed No Skip-kNN (NS-kNN)144, a modified version of the original 
kNN formulation that determines which missing values are likely MCAR or MNAR and 
imputes them appropriately. Because MNAR values stem from sensitivity limitations 
from analytical instruments, NS-kNN imputes values identified as MNAR with lower 
abundances than the original kNN methodology. While NS-kNN was not used in the 
workflow presented in this chapter, it is an important tool in metabolomics data pre-
processing and has already been shown in detail to effectively predict relative abundances 
of missing values better than several other imputation approaches. 
 
5.3.2 Identifying metabolic regulation using relative abundances 
I found that the regulation within the synthetic system could still be identified 
when using relative abundance data with SCOUR. When originally assessing SCOUR’s 
performance in Chapter 3, the metabolomics data were assumed to be in terms of 
absolute concentrations and not relative abundances. This is a significant finding, as it 
may expand SCOUR’s usability to the majority of current metabolomics datasets that 
have relative abundance values. SCOUR’s performance is likely unhindered because 
relative abundances are essentially scaled values of the true absolute concentrations. 
Using relative abundances in lieu of absolute concentration would change how quickly 
the reaction rate of a flux would appear to increase or decrease based on the abundance of 
controller metabolite(s) (versus concentration), but it would not change the underlying 




not cause a reaction to appear inhibited by a metabolite if the true absolute concentration 
actually induces the reaction. One limitation of using SCOUR in its current form is that 
the true flux reaction rates must be known to accurately predict regulation. When fluxes 




= 𝑆 ∙ 𝑣) using relative abundances, SCOUR could not identify regulatory 
interaction effectively. 
When using SCOUR on noiseless relative abundance data (20 repetitions using 
different sets of response factors with each repetition containing relative abundance data 
simulated from 15 sets of initial conditions), we observed that SCOUR could accurately 
predict the regulatory structure of the determined system (Figure 44A). All performance 
metrics for noiseless data were above 97% when identifying interactions with one or two 
controller metabolites. For noisy data (nT = 50, CoV = 0.05), SCOUR was still able to 
identify regulatory interactions with PPVs above 65% (Figure 44B), which is similar to 
the results found with the synthetic systems in Chapter 3 under the same conditions (the 
system used in this chapter performed slightly worse for one-controller metabolite 
interactions, but slightly better for two-controller metabolite interactions). To keep this 
proof-of-principle study as simple as possible, we decided to move forward with the 






Figure 44: SCOUR performance using relative abundances from the small synthetic 
model with unknown regulation.  
Accuracy, sensitivity, specificity, and positive predictive value metrics for SCOUR on A. 
noiseless and B. noisy (nT = 50, CoV = 0.05) data when predicting one- and two-
controller metabolite interactions. Bars represent the mean performance (n = 20 for each 
set of different response factors) and error bars represent the standard error of the mean. 
 
 
5.3.3 Inferring absolute concentrations from relative abundances and identified 
regulation 
During my efforts to combine all three frameworks together, I found that SCOUR 
must be executed before MetaboPAC. When first attempting to combine all three 
frameworks together, I initially attempted to infer absolute concentrations from relative 
abundances using MetaboPAC before using SCOUR and presumed I would then identify 
the regulatory interactions in the next step. However, it soon became apparent that some 
of the penalties within the optimization approach in MetaboPAC require the regulatory 
structure of the system to be known a priori or else the penalties would be ineffective. 
For example, the correlation penalties in MetaboPAC require the number of controller 
metabolites of a reaction to be known, but if the regulation of the system is uncertain, 
these penalties cannot be accurately applied. For this reason, SCOUR must be the first 





After identifying the regulatory topology of the determined system, we found that 
MetaboPAC was able to predict response factors with greater accuracy than randomly 
predicting response factors or using response factors of 500 when the kinetic structure of 
the system was unknown (i.e. only the optimization approach was used) (Figure 45A). If 
the kinetic equations of all reactions were assumed to be known, MetaboPAC predicted 
response factors with great accuracy (Figure 45B). 100% of the response factors were 
predicted within log2(1.3) error if the kinetic structure of the system was fully known. We 
used the identified response factors from both the optimization approach and kinetic 
equations approach to calculate sets of inferred absolute concentrations that were used 
with LK-DFBA in the next section. 
 
 
Figure 45: MetaboPAC performance on determined system with regulation.  
MetaboPAC compared to random response factors and response factors of 500 for the 
determined system with regulation using error ranges of log2(1.1), log2(1.3), and log2(1.5) 
when A. 0% and B. 100% of the kinetic equations are known. Bars represent the mean 
percent of predicted response factors within the error ranges for each method. Error bars 




When applying MetaboPAC in this workflow, we assumed that once the 




would also be known (if using the kinetic equations approach). In reality, there is a 
substantial amount of experimental work that needs to be performed to determine the 
kinetic formulation and kinetic parameters of a reaction, even if the substrates and 
allosteric regulators have been discovered. However, this is outside the scope of this 
thesis and the assumptions used here are reasonable for this proof-of-principle. 
Admittedly, one could argue that knowing the kinetic equations of all reactions in a 
system would defeat the need for LK-DFBA, which is why we apply both the results 
from the optimization approach and kinetic equations approach in the next section. 
However, it is important to reiterate that the results in Chapter 3 demonstrate that 
knowing only a percentage of kinetic equations can be beneficial and would further 
legitimize the use of LK-DFBA to model the remaining reactions in a system. 
 
5.3.4 Creating a metabolic model using inferred absolute concentrations and identified 
regulation  
Once both metabolite-flux interactions have been identified and absolute 
concentrations have been inferred, LK-DFBA can be applied to the determined system 
with regulation and a metabolic model can be constructed. Of the 15 ODE datasets used 
in the SCOUR and MetaboPAC steps, we chose one set (which includes 20 repetitions 
from different sets of response factors) to model with LK-DFBA. Along with the inferred 
absolute concentrations, the true flux profiles of each reaction were assumed to be 
known. We constructed four LK-DFBA models using the linear regression, non-linear 
regression, dimension reduction, and hyperplane kinetics constraint approaches and 




and v5 (the two effluxes out of the system) to evaluate which approach could recapitulate 
the ODE data the best. Both the MetaboPAC absolute concentrations inferred using 0% 
and 100% known kinetics were applied to LK-DFBA. 
The best LK-DFBA constraint approach was able to capture the general metabolic 
trends whether 0% or 100% of the kinetic equations were known. For the 0% known 
kinetic equations results, we observed that all LK-DFBA approaches were able to capture 
the general concentration profile trends of metabolites x1 and x3, but only LK-DFBA (LR) 
and LK-DFBA (NLR) could capture the trends of metabolites x2 and x4 (Figure 46). 
Similar trends were obtained when using the inferred absolute concentrations from the 
100% known kinetics results (Figure 47). In both of these cases, LK-DFBA (LR) and 
LK-DFBA (NLR) could accurately capture the dynamics of each metabolite, though 
these two kinetics constraint approaches slightly underestimated the metabolite profile for 
x1 when using only the optimization approach. Overall, LK-DFBA (LR) performed the 
best out of all the approaches for this system when using either 0% or 100% known 
kinetics results (Table 7), closely followed by the LK-DFBA (NLR) approach. LK-
DFBA (LR) could track the metabolite dynamics of the system when 0% of the kinetics 
were known almost as closely as when 100% of the kinetics were known, highlighting 
the usefulness of the optimization approach in MetaboPAC. In Table 7, the standard error 
of the median when using the kinetic equations approach was substantially lower for each 
LK-DFBA model compared to the standard error of the median when using the 
optimization approach due to the former approach identifying similar sets of response 





Figure 46: Comparison of LK-DFBA kinetic constraints on the determined system 
with regulation using inferred absolute concentrations from the MetaboPAC 
optimization approach.  
Each LK-DFBA kinetics constraint approach was fitted to absolute concentration data (n 
= 20 for each set of response factors) inferred with MetaboPAC when 0% of the kinetic 
equations were known. The models were simulated to recapitulate the original ODE data 
and the median of these predicted metabolite concentration time course profiles was 






Figure 47: Comparison of LK-DFBA kinetic constraints on the determined system 
with regulation using inferred absolute concentrations from the MetaboPAC kinetic 
equations approach.  
Each LK-DFBA kinetics constraint approach was fitted to absolute concentration data (n 
= 20 for each set of response factors) inferred with MetaboPAC when 100% of the 
kinetic equations were known. The models were simulated to recapitulate the original 
ODE data and the median of these predicted metabolite concentration time course 
profiles was calculated and presented in this figure. The dashed line represents the 
original ODE data. 
 
 We also fit each of the LK-DFBA approaches to the original ODE data and 
assumed all regulatory interactions were known (Figure 48). Interesting, we found that 
the LK-DFBA (LR) and LK-DFBA (NLR) models trained on inferred absolute 
concentration data (using the kinetic equations approach) and predicted regulatory 




trained on the ODE data with the correct regulation known a priori (Table 7). However, 
the differences in accuracy are negligible and the predicted profiles are very similar, 
which is not surprising because both SCOUR and MetaboPAC had predicted regulatory 




Figure 48: Comparison of LK-DFBA kinetic constraints on the determined system 
with regulation using the original ODE data and assuming all regulatory 
interactions were known.  
Each LK-DFBA kinetics constraint approach was fitted to the original ODE data (n = 1). 
The models were simulated to recapitulate the original ODE data and are presented in this 







 As a negative control, we fit each of the LK-DFBA approaches to the relative 
abundance data and assumed that the regulatory topology of the system was unknown 
(i.e. SCOUR and MetaboPAC were not used) (Figure 49). We found that LK-DFBA (LR) 
and LK-DFBA (NLR) performed substantially worse on relative abundance data with 
unknown regulation compared to our previous findings. These results demonstrate that 
SCOUR and MetaboPAC are significant steps in this metabolic modeling workflow. 
Interestingly, LK-DFBA (DR) and LK-DFBA (HP) improved in this case. This can be 
explained by the negative control assumption that there is no regulation in the system, 
meaning there are no reactions with multiple controller metabolites. Thus, the kinetics 
constraints in LK-DFBA (DR) and LK-DFBA (HP) are reduced to the constraints found 
in LK-DFBA (LR), which is why the NRMSE of these three approaches is equal in the 






Figure 49: Comparison of LK-DFBA kinetic constraints on the determined system 
with regulation using the relative abundance data and assuming all regulatory 
interactions were unknown.  
Each LK-DFBA kinetics constraint approach was fitted to relative abundance data (n = 
20 for each set of response factors). The models were simulated to recapitulate the 
original ODE data and the median of these predicted metabolite concentration time 
course profiles was calculated and presented in this figure. The dashed line represents the 







Table 7: Normalized root mean square error of the median concentration profile 
predictions by each LK-DFBA kinetics constraint approach compared to the ODE 
data. 
The standard error of the median (n = 20) is provided to the right of the NRMSE for the 
conditions that used inferred absolute concentrations or relative abundances. 








0.0397 ± 8.5766e-4 0.0513 ± 7.4302e-4 1.3288 ± 0.0104 1.6074 ± 0.0127 
NRMSE 
ODE data and 
known regulation 









In this chapter, I have presented a proof-of-principle workflow that combines our 
three frameworks into a streamlined process for developing metabolic models. Despite 
the fact that the frameworks were developed individually and are not optimized to work 
together in their current states, the work in this chapter has illustrated that they can all be 
used collectively. Furthermore, we demonstrated that without SCOUR and MetaboPAC, 
the modeling accuracy of LK-DFBA is substantially diminished when using relative 
abundance data and no regulatory information. With some improvements, our modeling 
approach will be suitable for a variety of biological systems with little necessary a priori 
information about the system of interest. In the next chapter, we discuss in detail some of 
the key areas in each framework that should be explored to further improve their 








 Throughout this thesis I have presented three novel frameworks that solve some 
of the most significant challenges in modeling metabolic systems. I have developed an 
approach for identifying allosteric regulatory interactions, a method for inferring absolute 
concentrations, and improvements to a previous modeling framework. Together, these 
platforms create a cohesive workflow for modeling metabolite dynamics in systems of all 
sizes. In this chapter, I discuss the contributions of this research to the scientific 
community and several areas of improvement that should be explored in the future for 
each framework. 
 
6.1 Thesis contributions 
As stated at the outset of this thesis, the overall goal of this work was to create a 
streamlined process for modeling metabolic systems given only raw metabolomics data 
and the stoichiometry of the system. Currently, there are many different modeling 
frameworks available, but most assume that the available metabolic data used for 
modeling has already been pre-processed into a useable form and the regulation of 
reactions is known a priori. A comprehensive modeling framework that begins with 
processing of raw metabolomics data and ends with the modeling of an allosterically 
regulated system would be incredibly valuable to the modeling community and would be 
a significant step toward building a dynamic genome-scale model with metabolomics 





One of the most difficult aspects of modeling metabolic systems is that their 
regulatory topologies are often unknown, especially for systems that are not well-studied. 
To overcome this obstacle, I have developed SCOUR, a stepwise machine learning 
platform that can predict the regulatory structure of interactions. I demonstrated that 
SCOUR is particularly useful at classifying reactions that are only controlled by a single 
metabolite and can also identify two-controller metabolite interactions with accuracies 
that allow for experimental validation. SCOUR is the first machine learning approach to 
determine the allosteric regulation of metabolic systems and it will be a significant tool 
for modeling metabolic reactions accurately. 
Another challenge in metabolic modeling frameworks is that although 
metabolomics data is primed to be a significant source of information for metabolic 
models, metabolomics is often omitted from these modeling platforms because the raw 
data are presented as relative abundances. To date, there have only been a few efforts that 
attempt to infer absolute concentrations from relative abundances without the need of 
chemical standards. In this thesis, I have presented a novel method, MetaboPAC, that 
infers absolute concentrations by leveraging the mass balances within a metabolic 
system. We determined that MetaboPAC can identify response factors (used to infer 
absolute concentrations) significantly more accurately than other methods when the 
kinetic equations of reactions are known. MetaboPAC is a powerful approach that will 
allow metabolomics data to be more easily integrated into metabolic modeling 
frameworks and other metabolic tools. 
Finally, while there have been many modeling frameworks that can either model 




there have been very few platforms that can efficiently model metabolite dynamics at the 
genome-scale. Our group recently developed LK-DFBA, a linear programming 
framework that addresses this issue and can capture metabolite dynamics at all scales. 
However, the initial iteration of LK-DFBA uses crude approximations in its kinetics 
constraints to model the interactions between metabolites and fluxes. Here, I have present 
three new methods for constructing kinetics constraints that are more biologically 
relevant. We discovered that the optimal kinetics constraint approach was dependent on 
the system being modeled and that the best kinetics constraint approach for fitting to the 
wildtype data was typically also the best approach for predicting other metabolic 
phenotypes. Additionally, we determined for the first time that LK-DFBA could be used 
to predict general metabolic trends found in experimental data of two biological systems. 
The addition of new kinetics constraints will allow LK-DFBA to be used on a wider 
variety of metabolic systems in the future. 
We have demonstrated that by combing the methods I have designed together, we 
can develop a dynamic metabolic model starting with only relative abundance data and 
the stoichiometry of the system. While the accomplishments in these aims have taken 
major strides toward achieving a cohesive metabolic modeling workflow, there are 
several areas of improvement discussed below that should be explored to make this an 
even more viable process.  
 
6.2 Improvements to SCOUR 
To the best of our knowledge, SCOUR is the first machine learning framework to 




2, I demonstrated that SCOUR is particularly useful at predicting reaction fluxes 
controlled by one or two metabolites and is significantly better at predicting three-
controller metabolite interactions than random classification. While these results are very 
promising, there are several avenues for improving the accuracy of SCOUR. 
 
6.2.1 Different machine learning algorithms 
In SCOUR, we use four different machine learning algorithms to construct the 
stacking classification model. In the first level of the model, random forest, k-nearest 
neighbors, shallow neural networks, and discriminant analysis were used to predict the 
set of controller metabolites that interact with a target flux. These outputs were fed to 
another discriminant analysis classifier in the second level of the stacking model that 
used the results from the four original algorithms to produce a final prediction. While 
these machine learning algorithms were found to be sufficient for the systems tested in 
this work and are some of the most common methods used in machine learning145 due to 
their robustness, there are many more algorithms that should be tested and could lead to 
improvements in prediction accuracy. More specifically, these improvements would 
allow more regulatory interactions to be identified and lead to fewer false positives, 
which is particularly important when identifying three-controller metabolite interactions. 
 One potential algorithm is the support vector machine (SVM) approach. SVMs 
classify data using hyperplanes, known as support vectors146, that separate classes by 
maximizing the distance between the data and the hyperplane. The most basic SVM 
method separates classes linearly, which can limit its effectiveness in many cases where 




SCOUR but found it to classify metabolite-flux interactions poorly. However, there are 
many kernel functions that can be used with SVM to perform non-linear classification. 
Kernel functions transform and map the data to a different dimensional space so that 
SVM can more easily separate non-linear classes147, but it is important to note that using 
kernel functions can lead to overfitting if they are not used correctly148. 
Another classifier that could be tested in the SCOUR framework is Naïve Bayes 
classification149. Naïve Bayes is a probabilistic algorithm that uses Bayes theorem to find 
the probability that a datapoint belongs to one class or another based on the given 
predictors (i.e. features). The biggest downside of using Naïve Bayes is that it assumes 
that the predictors are independent of each other, which is often not the case (and is not 
the case with the current features used in SCOUR). Nevertheless, Naïve Bayes has been 
used in metabolomics contexts before150, 151. Depending on the data being classified, there 
are several versions of Naïve Bayes, such as Bernoulli Naïve Bayes if features are 
Boolean or Gaussian Naïve Bayes if the features are continuous and exhibit a Gaussian 
distribution. 
The second level classifier of the stacking model can accept many more than four 
inputs, so the addition of SVM, Naïve Bayes, or other machine learning algorithms could 
improve the prediction of the model. However, it is important to note that the inclusion of 
additional algorithms can also lead to bias toward specific classes of algorithms if there 
are multiple classifiers in the stacking model that are similar. 
Another possibility for improvement of the overall approach could be the 
inclusion of unsupervised algorithms. All machine learning algorithms currently used in 




class “labels” for the samples in the training data (i.e. the interactions in the training data 
are labeled as true positives or true negatives). Unsupervised learning does not require 
labeled classes and categorizes the data in groups or clusters of datapoints. Because the 
autogenerated training data are already labeled, it may not be appropriate to use 
unsupervised methods in the stacking model. However, unsupervised methods may be 
useful in developing new features that could improve the classification of different types 
of metabolic interactions. This process is called feature learning152 and it can use 
unsupervised learning algorithms to identify information in the data that best separates 
true positive and true negative interactions. One common unsupervised machine learning 
method is principal components analysis128, which linearly transforms the original 
variables in the data (e.g. concentrations, reaction rates, or features) into new orthogonal 
variables called principal components that capture as much of the variance in the data in 
as few variables as possible. Another unsupervised method is k-means clustering153, 
which separates the data into k groups by identifying centroids in each group that 
optimally cluster the data. Besides feature learning, unsupervised learning methods are 
also often used in feature selection, whereby the features that contribute the most to the 
accuracy of the classification model are identified and the remaining features that do not 
contribute substantially, or even undermine classification, are removed154. 
 
6.2.2 Including more biologically relevant interactions in the training data 
 Along with creating a framework to classify metabolic interactions, we also 
developed a method for autogenerating biologically relevant training data. Metabolomics 




learning with these data, as most algorithms require an abundance of training 
information. The autogeneration method addresses this problem by emulating a multitude 
of different biological-like metabolite concentration and flux profiles. Our results 
demonstrate that these autogenerated datasets were able to successfully train the 
classification models used in SCOUR to predict regulatory interactions. To further 
improve the autogeneration method, some of the formulations for generating data could 
be modified. 
 To generate flux data, we use BST kinetic equations as the basis for all reactions 
in the autogeneration process. We chose to use BST because it is regarded as an all-
purpose metabolic modeling approach that is flexible and can capture the kinetics of 
many different types of reactions97. However, many metabolic models use other types of 
kinetics, such as Michaelis-Menten or Hill kinetics, because they more closely represent 
the behavior of enzymes155. The two biological systems used to assess SCOUR use a 
mixture of Michaelis-Menten, Hill, and mass action kinetics, so it is possible that using 
other kinetic formulations in place of or in addition to BST would improve the potential 
for the autogenerated training data to lead to predictions of different types of metabolic 
interactions. In the future, when metabolomics and fluxomics data become more readily 
available, real data could supplement the autogenerated training data and provide 
additional insight about how biological interactions function and should be modeled. 
 
6.2.3 Modification of autogeneration methods to include topological information 
 With all machine learning frameworks, there is always potential for improvement 




steps of SCOUR, we created different features that were specific to the number of 
putative controller metabolites that were being examined. One group of features that are 
not currently used in SCOUR but could be potentially applied across all steps are features 
that represent topological information about the system. The topology of the system 
could pertain to only the metabolites, the fluxes, or a combination of both.  
Many possible topological features stem from graph theory, including the number 
of edges, centrality score, network diameter, network density, and vertex betweenness 
centrality156. Topological features have been previously used in other biological contexts 
with machine learning to predict novel metabolic pathways99. Because the topology of 
metabolites and fluxes is one of the defining features of a metabolic system, including 
this information could significantly improve the ability of SCOUR to identify regulatory 
interactions. The basis of including topological features is that reactions with similar 
topologies could also have comparable regulatory structures. 
In its current state, SCOUR is unable to use topological information as features 
because the autogenerated training data has no inherent topology. As mentioned in the 
previous section, as both metabolomics and fluxomics data become more available, 
SCOUR is primed to use biological data as training data and topological features can then 
be implemented. Alternatively, the autogenerated training data method could be modified 
to include some pseudo-topological information for each artificial interaction. If 
topological information can be incorporated within SCOUR, several new types of 






6.2.4 Using SCOUR on experimental data 
 To continue to prove SCOUR is a viable framework for identifying regulatory 
interactions, the next step is to test SCOUR on experimental data. Up to this point, we 
have assessed SCOUR on data simulated from two biological models and have added 
noise to emulate realistic data. When moving to experimental data, SCOUR should first 
be used on a well-studied system, such as E. coli, where the regulatory topology is well 
known. This will allow us to determine if SCOUR can truly identify regulatory 
interactions that are already known. Once this has been achieved, SCOUR can be used on 
other metabolic systems to discover new regulatory interactions that have not been 
established in the literature. Each of the new regulatory interactions predicted by SCOUR 
will need to be experimentally validated and through this process we can determine how 
many of these predicted interactions truly exist in the system. 
 
6.3 Improvements to MetaboPAC 
As the novelty of MetaboPAC is significant and the work presented in this thesis 
demonstrates its feasibility in a proof-of-principle context, the simplifying assumptions 
made in its implementation are well within reason. However, these assumptions entail 
some limitations that should be addressed in future work. 
 
6.3.1 Non-linear relationships 
 Perhaps the biggest assumption of MetaboPAC is that the relationship between 
relative abundances and their absolute concentrations is linear. However, in reality some 




inequality constraints to be strictly linear (or quadratic if using the NLR method) to 
maintain an LP (or QP) structure, MetaboPAC does not use linear programming and 
already contains non-linearities within both the optimization and kinetic equations 
approach. This makes it easy to integrate non-linear absolute concentration relationships 
in MetaboPAC, whether they are simple polynomials or more complex. While the 
implementation of non-linear relationships is straightforward, determining which 
response factors should have linear or non-linear relationships is more difficult if not 
known a priori. 
 In the simplest non-linear scenario, we can assume that the equation used to infer 
absolute concentrations takes the form: 
 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝐴𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 = (𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛)𝑝 × 𝑅𝐹𝑇  (Equation 9) 
 
where p is some parameter that defines the non-linear relationship and RFT is the true 
response factor. For linear relationships, p is set to one and this equation reduces to 
Equation 5. With the inclusion of p, the total number of parameters that need to be 
inferred (including the response factors) doubles. This will likely slow down MetaboPAC 
and make it more difficult to identify the response factors because not only are there 
more parameters, but it is also possible that identifiability of p could be more difficult 
(i.e. there are multiple values of p that are optimal). Nevertheless, the original underlying 
framework is still sound. The roles of the mass balances in the kinetic equations approach 
and the penalties in the optimization approach should not change whether the relationship 




meaning that the biggest necessary adjustment is the implementation of  Equation 9 in the 
mass balances and optimization penalties. One important matter to consider in the kinetic 
equations approach is that because there are double the number of parameters (i.e. 
unknowns), it is more likely for the system of non-linear equations to be 
underdetermined, and thus there may not be a unique solution for the response factors. A 
higher percentage of known kinetic equations or inclusion of more timepoints may be 
necessary to avoid this pitfall when considering non-linear relationships. 
 
6.3.2 General improvements to the optimization approach 
 Both the kinetic equations approach and optimization approach are currently 
essential components of MetaboPAC. However, it is unsurprising that the kinetic 
equations approach can predict more accurate response factors, as it uses more 
mathematical and biological information. Unfortunately, in many biological systems, the 
kinetics of reactions are not generally known, making it critical to improve the 
optimization approach for effective predictions when there is minimal a priori biological 
knowledge. In some cases where 0% of the kinetics are known, we have observed that 
MetaboPAC still outperforms random response factors and response factors of 500, 
which illustrates that the optimization approach can be effective alone. There are a few 
opportunities to explore to improve the effectiveness of the optimization approach. 
 Because the principle behind the optimization approach is to eliminate response 
factors that infer absolute concentrations (and indirectly infer fluxes) that are not 
biologically feasible, there are several options for identifying infeasible response factors. 




concentrations and fluxes can greatly constrain the amount of allowable response factors 
when used in conjunction with the current penalties. However, this entails biological 
insight or information that may often not be available. Second, there have been other 
efforts in the FBA space that have attempted to remove flux distributions that are 
biologically infeasible whose methods could be translated to MetaboPAC. For example, 
several approaches have been developed to remove fluxes that are thermodynamically 
unlikely37, 38 or have improbable metabolic energy totals (calculated as the norm of the 
flux distribution)157. Employing these methods in MetaboPAC could eliminate some 
unlikely response factors, but it is important to note that some of these methods assume 
that absolute concentrations are already known and thus would need to be adjusted 
accordingly to use relative abundances. Finally, the penalties used in the optimization 
approach could be further improved, whether it is the addition of new penalties that can 
identify poor response factors or adjusting the weights of each penalty. 
 
6.3.3 Developing a platform for predicting confidence in inferred response factors  
One significant extension to MetaboPAC that would improve its usability is a 
method for predicting the confidence in its inferred response factors. From our results, we 
found that the response factors identified when using the kinetic equations approach were 
relatively stable for all metabolites across the 48 repetitions of the non-linear least-
squares solver with different initial seeds. In contrast, we observed that the optimization 
approach was often able to predict response factors for some metabolites more easily than 
others. The effectiveness of the penalties in the optimization problem are likely better for 




response factors for those particular metabolites. This would cause the width of the 
distribution of possible response factors in the 48 repetitions to be thinner for these 
metabolites and possibly increase the prediction accuracy when calculating the median of 
the response factor distribution. 
To improve the usefulness of MetaboPAC, an auxiliary framework should be 
developed that assesses the confidence in the predictions generated by the optimization 
approach based on the distributions for each response factor. For example, thinner 
distributions would suggest higher confidence, whereas a wide distribution would signal 
low confidence. Other characteristics of the distribution of response factors that could be 
useful for predicting confidence include the standard deviation of the distribution, the 
number of peaks in the distribution, and the normality of the distribution. We currently 
only have an overall sense of the accuracy of the response factors inferred by 
MetaboPAC, but do not know which individual response factors are closest to their true 
values. Creating a platform for determining the confidence in the results produced by 
MetaboPAC would allow one to infer absolute concentrations of only metabolites for 
which the response factors were predicted with high confidence. 
 
6.4 Further improvements to LK-DFBA 
In this thesis, we have significantly improved on the original LK-DFBA 
framework, introducing three new approaches for constructing kinetics constraints. We 
have also demonstrated for the first time that LK-DFBA is a feasible platform for 
predicting different metabolic phenotypes in two biological systems. Because it is the 




we have focused on how these kinetics constraints can be improved. However, along with 
the constraints that define the feasible search space of the linear program, the objective 
function is the other key component in a CBM. Here, we discuss how optimizing the 
objective function in LK-DFBA could significantly improve modeling performance. 
In CBMs, most stoichiometric matrices of biological systems are underdetermined 
(i.e. there are a greater number of reactions than metabolites), meaning there are an 
infinite number of possible flux profile solutions to the problem. To identify the most 
plausible flux profile, an objective function is used that is often based on some cellular 
goal, such as maximizing biomass. One could argue that because the objective function 
identifies a single best solution, it is as important as the equality and inequality 
constraints that define the feasible search space in the LP. 
In our work to improve LK-DFBA with new kinetics constraints, we tested LK-
DFBA on one synthetic system and two biological systems. For the synthetic system, we 
chose the only efflux out of the system as the objective function, as it seemed the most 
logical choice. For the L. lactis system we assumed the objective function was to 
maximize lactate production and for the E. coli system we assumed the objective function 
was to maximize all of the effluxes out of the cell. CBMs of biological systems typically 
use an objective function that maximizes a dedicated biomass flux reaction158, but 
because we constructed the biological LK-DFBA models using information from two 
kinetic models rather than constraint-based models, there was no predetermined objective 
function. Nevertheless, the objective function we chose led to results sufficient to 
demonstrate that LK-DFBA could model metabolite dynamics in both organisms. 




optimized instead of using our best guesses. In addition to examining how the objective 
function in LK-DFBA can be optimized, in this section we also discuss how modeling of 
cofactor metabolites can be improved and how LK-DFBA can be applied to metabolic 
engineering. 
 
6.4.1 Existing methods for optimizing objective functions 
 Optimizing objective functions is not a novel idea in the realm of metabolic 
modeling. There have been several works that address the issue of objective function 
optimization, including ObjFind130 and BOSS131. ObjFind creates a bilevel optimization 
problem that simultaneously attempts to maximize an objective function and minimize 
the flux distribution error between predicted and experimental data. This optimization 
approach identifies the optimal weights of the objective function that best fit the data (the 
c vector in Equation 1). BOSS is another bilevel optimization approach similar to 
ObjFind. Instead of determining the weights of available fluxes in the system, BOSS 
creates an additional flux that has the sole purpose of acting as the objective function. 
This extra flux term allows for more flexibility than ObjFind because it allows the 
stoichiometric amounts of individual metabolites to be more readily configured within 
the objective function. More recently, proteomics data have been used to determine the 
most essential fluxes in an objective function, arguing that the maximization of biomass 
is not suitable in certain conditions, such as when a cell is under stress158. Another 
approach was developed to complement DFBA by testing various objective functions 
simultaneously and pinpointing the best without the use of a bilevel optimization 




could significantly improve modeling accuracy. 
 
6.4.2 Optimizing the objective function in LK-DFBA 
 There are two obstacles that must be addressed in order to use ObjFind or BOSS 
with LK-DFBA. First, LK-DFBA contains novel linear kinetics constraints not found in 
the prototypical FBA framework, which can be challenging to implement within the 
bilevel optimization. Second, the solution vector in ObjFind and BOSS is a single set of 
flux values, while the solution vector in LK-DFBA is a time course of metabolite 
concentrations and flux values. If one were to use ObjFind or BOSS on LK-DFBA as is, 
the two optimization frameworks would identify an objective function that tries to 
simultaneously maximize metabolite concentrations and fluxes (whereas the current LK-
DFBA only maximizes one or the other) and the objective function would simultaneously 
consider metabolites and fluxes across all timepoints as independent measures. As a 
result, different metabolites and fluxes could be maximized at different timepoints. While 
biologically it is possible and even likely that the cellular objective may not always be 
constant, it is unlikely to deviate in a short time span; this limitation would not be 
accounted for if one were to directly apply ObjFind and BOSS to LK-DFBA. 
 In an attempt to create a framework similar to ObjFind and BOSS that could work 
with LK-DFBA, I created two optimization approaches to search for the ideal objective 
function. To emulate ObjFind, the first approach attempted to optimize the weights of the 
c vector (Equation 1) for the available fluxes by minimizing the error between ODE data 
and the predictions generated by an LK-DFBA model fitted to the ODE data. In the 




a new flux was created and the stoichiometric contributions of each metabolite to the 
biomass was optimized, similar to BOSS. Like the first approach, the second approach 
minimized the prediction errors of the LK-DFBA model. 
 When I tested these two approaches on a small synthetic model as well as a model 
of E. coli, it quickly became apparent that the optimizer could easily become trapped at 
local minima. Unlike ObjFind and BOSS, which uses the duality principle in their bilevel 
optimizations to simultaneously identify the best objective function and the optimal 
solution to the FBA linear program, the approaches I have created are two nested 
optimization problems that are solved in serial. The objective functions determined by 
my approaches were not consistent across repetitions and did not seem to have any 
biological relevance for the E. coli model. For example, when using the first approach, 
there did not seem to be a preference for maximining any of the effluxes, which one 
might otherwise expect. 
One important point to note is that when optimizing these objective functions, the 
LK-DFBA model used parameters estimated using the LR approach, which does not 
require an objective function to be known for parameter estimation. If using the LR+ 
approach, which has been shown to recapitulate training data better than the LR method, 
it is important to note that LR+ estimates parameters by minimizing the error between 
LK-DFBA and the training data, meaning LR+ uses an LK-DFBA objective function to 
predict metabolite and flux time course data during parameterization. If the LR+ 
approach is used during objective function optimization, whether the kinetics constraint 
parameters are identified before optimization of the objective function begins or at the 




 While my initial attempts to optimize the objective function of LK-DFBA were 
unsuccessful, this undertaking should be reexamined in the future as it is a key area 
where LK-DFBA could be improved. With some modifications to ObjFind or BOSS, the 
kinetics constraints of LK-DFBA could be incorporated into the bilevel optimization 
problem, similar to the typical FBA flux constraints already included in both frameworks. 
Additionally, instead of creating a single linear program within LK-DFBA that includes 
all timepoints together, LK-DFBA could be reformulated so that each individual 
timepoint would be part of a separate linear program. This would possibly allow ObjFind 
or BOSS to more easily determine an optimal objective function at a single point in the 
time course that could then be applied to all timepoints. However, dividing LK-DFBA 
into separate timepoints would fundamentally change how the framework determines the 
optimal concentration and flux distributions and would need to be explored in more 
depth. 
 
6.4.3 Improving predictions of cofactor metabolite concentrations 
 In Chapter 4, we determined that LK-DFBA could capture the metabolite 
dynamics of a few key metabolites in the biological systems examined. However, LK-
DFBA struggled to accurately predict changes in cofactor concentrations. Cofactors, such 
as NADH and ATP, are involved in many different reactions, leading LK-DFBA to often 
predict that these metabolites are rapidly accumulating and depleting. Before it can 
become a widely used metabolic modeling framework, LK-DFBA will need to be able to 
model these cofactors and there are a few possible changes to LK-DFBA that could 




 Because cofactors often participate in multiple reactions either as substrates or 
products, calculating the change in concentration of these metabolites involves many 
different kinetics constraints within LK-DFBA. On the other hand, other metabolites, 
such as lactate in the L. lactis model, only require a single constraint to calculate 
metabolite accumulation or depletion, which makes tracking these metabolites easier 
(Figure 37). A method for combining the constraints used to calculate the accumulation 
or depletion of cofactors into a single constraint could improve the predictions of these 
metabolite concentrations. Unlike the dimension reduction and hyperplane approaches in 
Chapter 4, which create a single constraint for reactions with multiple controller 
metabolites, this new approach would create a single constraint for multiple reactions. 
While this method could make it easier to track the dynamics of cofactors, it will be 
important to ensure that a single kinetics constraint does not oversimplify the framework. 
 Another possible approach for improving the prediction performance of cofactor 
concentrations is to add new constraints to the linear program that limit the change in 
concentration of these metabolites across each timepoint. These cofactors currently 
accumulate and deplete at rates that are not biologically likely. By restricting how quickly 
these concentrations can change based on the training data, LK-DFBA could more 
accurately model the behavior of these cofactors. 
 
6.4.4 Using LK-DFBA in metabolic engineering 
 In this thesis, we have demonstrated that LK-DFBA can capture the general 
trends of different metabolic phenotypes in biological systems. As we continue to 




We have already determined that LK-DFBA can predict some changes in metabolism 
when genetic perturbations are introduced to a system, but we have not tried to use LK-
DFBA models to engineer an organism to efficiently produce a specific metabolite. 
Because LK-DFBA retains a linear programming structure, we envision that it could be 
integrated with current FBA strain design tools, including OptKnock126, which identifies 
genetic knockouts for the overproduction of chemicals of interest. Like ObjFind for 
optimizing objective functions, OptKnock also uses a bilevel optimization structure and 
the same concerns discussed in the previous section will need to be investigated. Because 
OptKnock only focuses on gene knockouts and no other types of genetic perturbations 
that could add complexity, it is an ideal platform when first exploring how LK-DFBA 
can be used for strain design. Incorporating LK-DFBA in OptKnock is a critical first step 
toward demonstrating LK-DFBA can be a useful modeling framework for metabolic 
engineering and other applications in the future. 
 
6.5 Closing remarks 
The work presented in this thesis addresses three of the greatest challenges when 
attempting to model metabolic systems using metabolomics data. First, I introduced a 
stepwise machine learning platform for identifying the allosteric regulatory structure of 
metabolic systems, which is often unknown but critical to building accurate models. 
Second, I developed a novel method for inferring absolute concentrations from raw 
metabolomics data by leveraging the mass balances in a metabolic system. Finally, I 




the first time that the modeling framework can predict different phenotypes in two 
biological systems. 
SCOUR, MetaboPAC, and LK-DFBA are each of significant importance in the 
process of developing metabolic models. The regulatory interactions predicted by 
SCOUR can lead to more accurate modeling of metabolic systems and the absolute 
concentrations inferred by MetaboPAC will improve the ability to integrate 
metabolomics data with computational tools. The new kinetics constraints implemented 
in LK-DFBA allow the framework to model a wider variety of metabolic systems. When 
combined together, these three platforms create a cohesive workflow that starts with the 
pre-processing of metabolomics data and ends with a fully constructed dynamic model 
with integrated allosteric regulatory information.  
In this chapter, we have discussed several suggested areas to explore that could 
further improve SCOUR, MetaboPAC, and LK-DFBA. Even with each framework in its 
current state, we have already determined that they can be used together to model a 
simple, yet meaningful, metabolic system. As the amount of available metabolomics data 
continues to rapidly expand, this cohesive workflow will be ready to take advantage of 














Figure 50: LK-DFBA performance on noisy synthetic model data, nT = 50, CoV = 
0.05. 
Each constraint approach was used to fit parameters to noisy (nT = 50, CoV = 0.05) wild-
type (WT) data and then used to simulate the WT system and the system with in silico 
genetic perturbations with fluxes v2, v3, or v4 down- or up-regulated. Dark green boxes 
represent the lowest average NRMSE (N = 10) within each phenotype for each synthetic 
model, while dark red boxes represent the highest average NRMSE. The cells with 
bolded white numbers indicate the LK-DFBA approach that best fits the WT data. Cells 
with white numbers are generally consistently green, indicating that fitting to WT data is 





Figure 51: LK-DFBA performance on noisy synthetic model data, nT = 50, CoV = 
0.15. 
Each constraint approach was used to fit parameters to noisy (nT = 50, CoV = 0.15) wild-
type (WT) data and then used to simulate the WT system and the system with in silico 
genetic perturbations with fluxes v2, v3, or v4 down- or up-regulated. Dark green boxes 
represent the lowest average NRMSE (N = 10) within each phenotype for each synthetic 
model, while dark red boxes represent the highest average NRMSE. The cells with 
bolded white numbers indicate the LK-DFBA approach that best fits the WT data. Cells 
with white numbers are generally consistently green, indicating that fitting to WT data is 






Figure 52: LK-DFBA performance on noisy synthetic model data, nT = 15, CoV = 
0.05. 
Each constraint approach was used to fit parameters to noisy (nT = 15, CoV = 0.05) wild-
type (WT) data and then used to simulate the WT system and the system with in silico 
genetic perturbations with fluxes v2, v3, or v4 down- or up-regulated. Dark green boxes 
represent the lowest average NRMSE (N = 10) within each phenotype for each synthetic 
model, while dark red boxes represent the highest average NRMSE. The cells with 
bolded white numbers indicate the LK-DFBA approach that best fits the WT data. Cells 
with white numbers are generally consistently green, indicating that fitting to WT data is 
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